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ABSTRACT
The circadian timing system influences many aspects of behaviour and
physiology and previous evidence suggests a circadian modulation of drug-seeking
behaviour and responsiveness to drugs of abuse. To further characterize daily rhythms
in reward, diurnal variations in the rewarding value of systemic amphetamine and of the
natural reward behaviour mating, were assessed. Diurnal rhythms were evident for both
mating and amphetamine-related reward, but differed in the pattern of their timing with
a peak during the mid-dark period for mating reward, and peaks during the late night
and midday for amphetamine reward, with a nadir prior to the light-to-dark transition.
To identify potential mechanisms for rhythmicity in reward, diurnal rhythms in
expression levels of core clock proteins (Per1 and BMAL1) and tyrosine hydroxylase
(TH), as well as makers of neural activation (cFos) were examined. Western blot
analyses revealed rhythmic Per1 and Bmal1 protein levels in the nucleus accumbens
(NAc) but not ventral tegmental area (VTA). By contrast, TH protein levels were
rhythmic in both the NAc and VTA, with a peak in NAc coinciding with the peak of sex
reward, while the peak in the VTA associated with the peak in amphetamine reward.
Rhythmic expression of cFos immunoreactivity (IR) was observed in NAc, medial
prefrontal cortex (mPFC), and VTA, with peak expression during the late night.
Absence of clock gene oscillations in the VTA suggests that rhythms in mesolimbic
activity are driven by timing signal originating elsewhere; and the mPFC was
hypothesized to be a key mediator. The effects of mPFC lesions or inactivation on
diurnal rhythms in cFOS-IR and amphetamine CPP were determined at previously
observed peak and nadir times. Lesions attenuated the peak in cFos-IR in the NAc,

ii

eliminating the diurnal rhythm, but had no effect on VTA rhythms. Moreover, daily
differences in amphetamine reward were eliminated by mPFC lesions and inactivation,
via an increase at the nadir. Together, these results indicate that diurnal rhythms of
mesolimbic activity may be functionally relevant for rhythms in reward and that the
mPFC plays a critical role in mediating such diurnal fluctuations.

Keywords: reward, circadian, sexual behaviour, psychostimulants, amphetamine,
clock genes, Per1, BMAL1, dopamine, conditioned place preference, cFos, medial
prefrontal cortex, excitotoxic lesions, GABA agonists, mesolimbic system,
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CHAPTER 1:
Introduction1

1

Sections 1.1-1.4 were adapted from Webb IC, Baltazar RB, Lehman MN, Coolen LC
(2009). Bidirectional interactions between the circadian and reward system: is restricted
food access a unique zeitgeber? European Journal of Neuroscience, 30(9),1739-48.
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Most organisms must select between different stimuli in their environment to
maximize their chances for survival. To facilitate this selection, mammals possess
specialized brain systems that allocate value to external stimuli (Tobler, Fiorillo, &
Schultz, 2005). This determines whether a given stimulus is approached or avoided, and
with what priority. Continued experience with the stimulus alters neural activity and
structure in these circuits, and dictates the intensity and direction of future behavioural
responses (Pitchers et al., 2010; Wolf, Sun, Mangiavacchi, & Chao, 2004). In general,
stimuli that increase the frequency of the behaviours required to obtain them, are termed
rewards (Kelley, 2004). Rewarding stimuli include resources necessary for survival, such
as food and sex, but also substances with no apparent biological relevance, such as drugs
of abuse. The value of a rewarding stimulus is subjective, and at any given time depends
on various factors, such as the organisms internal homeostatic drive, its affective state,
and its genetic background (Berridge, 2004; Murray, 2007; Nestler, 2000). Similarly,
researchers have reported that the time-of-day also affects many rewards and rewardmotivated behaviours. The mammalian circadian system regulates diurnal rhythms in
many biological processes (Dibner, Schibler, & Albrecht, 2010), and has been reported to
regulate the activity in brain areas related to reward. Likewise, the circadian system is
also influenced by the timing of rewards (Kosobud et al., 2007), suggesting a
bidirectional interaction between these two systems. The nature of this interaction
remains poorly understood. The purpose of this work was to demonstrate the circadian
regulation of reward. In particular, to provide a comprehensive characterization of daily
rhythms in reward, natural and drugs of abuse, demonstrate their circadian properties, and
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elucidate the underlying neural mechanisms that mediate them. The following literature
review will summarize the general properties of the mammalian mesolimbic reward and
circadian systems, and discuss the current evidence for circadian regulation of reward.

1.1 THE MESOLIMBIC REWARD SYSTEM
Anatomical mapping of reward-related brain areas, facilitated by the discovery
that rats will learn to bar press when it is contingent upon electrical self-stimulation (Olds
& Milner, 1954), has indicated that this system is comprised of a distributed series of
brain structures located in both the midbrain and the basal forebrain. Central to this
system is the mesolimbic dopaminergic pathway which originates in the ventral
tegmental area (VTA) and projects via the medial forebrain bundle to the nucleus
accumbens (NAc), amgydala, hippocampus, prefrontal cortex (mPFC) and other rostral
structures (Kelley, 2004). As a whole, this system is thought to be the common substrate
for reward associated with both natural stimuli and drugs of abuse as it is critical for the
expression of appetitive behaviour in general (Ikemoto, 2007; Kelley & Berridge, 2002;
Koob, 1992).

To date, the most thoroughly characterized reward-related neurotransmitter is
dopamine and, though there exists a large body of literature, its functional role in this
system remains a matter of debate (Berridge, 2007). Reward is comprised of multiple
components including “liking” or the hedonic aspects associated with consumption and
“wanting”, which reflects increased incentive salience (i.e., the attraction to external
stimuli with appetitive properties). There is no compelling evidence implicating
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dopamine in hedonic effects but a wealth of data suggests a role in reward seeking and
incentive motivation (Berridge, 2007; Ikemoto & Panksepp, 1999). Recent evidence
suggests that the induction of reward-related neuroplasticity is dependent upon the
coordinated release of both dopamine and glutamate in the NAc (Kelley, 2004). GABA,
serotonin, endocannabinoids, and opioid peptides are also involved in the regulation of
the reward system (Koob, 1992) with the latter group of transmitters likely mediating
hedonic effects via release in the NAc (Pecina, 2008).

1.2 THE CIRCADIAN SYSTEM
1.2.1 Circadian rhythms
Rhythmic control of essential life processes is ubiquitous throughout nature (BellPedersen et al., 2005; Rapp, 1987). Nearly all organisms have developed mechanisms to
drive daily rhythms in cellular processes, physiology, and behaviour (Dunlap, 1996,
1999). In mammals, increased complexity has driven the development of a multioscillator systems controlled hierarchically by a master time-keeping mechanism located
in the brain (Ko & Takahashi, 2006; Mohawk, Green, & Takahashi, 2012; Reppert &
Weaver, 2002). Precise control of the timing of biological processes has obvious
advantages; it allows for the allocation of valuable resources to times of greatest benefit
and maximizes biological efficiency by synchronizing complementary life processes.
The role of a master clock is to organize the many behavioural and physiological rhythms
to anticipate regularly occurring external events, thus conferring ecological validity upon
this system. The particular environmental cycle that entrains circadian rhythms is
referred to as a zeitgeber, or ‘time-giver’. The most consistent zeitgeber is the 24-hr
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cycle of light and dark. As a result, clock mechanisms tend to oscillate with a near 24-hr
cycle, termed circadian from the Latin for ‘approximately a day’. The circadian system
is typically synchronized to the external daily light cycle, but can entrain to other
zeitgebers that confer a survival advantage, such as the timing of rewarding stimuli
(Angeles-Castellanos, Salgado-Delgado, Rodriguez, Buijs, & Escobar, 2008; Kosobud, et
al., 2007; Mendoza, Angeles-Castellanos, & Escobar, 2005).

1.2.2 The master circadian clock
The master mammalian circadian oscillator is located in the suprachiasmatic
nucleus (SCN) in the ventral portion of the hypothalamus (A. C. Liu, Lewis, & Kay, 2007;
Reppert & Weaver, 2001, 2002; X. Zheng & Sehgal, 2008), a heterogeneous structure
that is subdivided into shell and core regions. In general, the shell and core have two
separate and unique functions. The shell region contains the endogenously selfsustaining clock mechanism, while the core is responsible for entraining the master clock
to rhythms in the environment. The self-sustaining cellular clock mechanism consists of
positive and negative transcriptional and translational feedback loops that drive
oscillations of clock genes and their protein products (DeBruyne, Weaver, & Reppert,
2007; Ko & Takahashi, 2006; Reppert & Weaver, 2001, 2002). An entire cycle takes
approximately 24-hours. The positive loop of this mechanism is made up of the
transcription factors BMAL1 and Clock, which bind to E-boxes downstream of the clock
genes per(1&2) and cry and regulate their expression. Once transcribed and translated,
the corresponding clock proteins together make up the negative loop of the clock
mechanism and inhibit bmal1 and clock expression. These four clock genes make up the
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central gears of the molecular clockwork mechanisms. Many additional core clock genes
have been identified since, and are responsible for fine-tuning the timing of the circadian
clock (Ukai & Ueda, 2010). Molecular clock gene oscillations culminate in the
expression of rhythmic output signals from the SCN, including electrical, endocrine and
metabolic, that synchronize subordinate extra-SCN oscillators (Albrecht, 2012; Dibner, et
al., 2010).

1.3 CIRCADIAN INFLUENCES ON THE REWARD SYSTEM
1.3.1 Diurnal variation in reward and motivation
Initial support for circadian regulation of reward comes from research on
addiction and drugs of abuse in humans. Long-standing anecdotal evidence of a daily
rhythm in the admittance of drug overdose patients to the emergency room was
formalized by studies reporting a peak in the evening (Morris, 1987; Raymond, Warren,
Morris, & Leikin, 1992). Similarly, time-of-day differences in the efficacy and
pharmacology of drugs-of-abuse have been known for some time (Ede, 1973; Erickson,
Lee, Zautcke, & Morris, 1998; Lemmer, 1996), and nicotine self-administration is
reported to be highest during the early morning and late evening (Mooney, Green, &
Hatsukami, 2006). In animals, behavioural responses to many reward-related stimuli also
vary by time-of-day. For instance, a diurnal rhythm in septal or hypothalamic electrical
brain self-stimulation was observed in rodents that peaks during the middle-to-late dark
(active) phase of the light/dark cycle, and persists under constant conditions with a near
24 hr period, suggesting it is circadian in nature. (Terman & Terman, 1970, 1975).
Additionally, self-administration of addictive substances, such cocaine and alcohol, also
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varies by time-of-day for monkeys and rodents (Baird & Gauvin, 2000; Deneau, Yanagita,
& Seevers, 1969; Gauvin et al., 1997; Roberts & Andrews, 1997; Roberts, Brebner,
Vincler, & Lynch, 2002). Time-of-day differences have been reported in several other
behavioural measures of drug reward, including drug-induced conditioned place
preference (CPP), sensitization, and locomotor activity (Abarca, Albrecht, & Spanagel,
2002; Akhisaroglu, Ahmed, Kurtuncu, Manev, & Uz, 2004; Gaytan, Lewis, Swann, &
Dafny, 1999; Kurtuncu, Arslan, Akhisaroglu, Manev, & Uz, 2004). The general
tendency amongst these findings is for increased drug consumption and reward during
early-middle light-phase. Conversely, there is also evidence that drugs of abuse alter
circadian rhythms and normal sleep-wake cycles (Hasler, Smith, Cousins, & Bootzin,
2012; Kosobud, et al., 2007), giving credence to bidirectional interaction between the
reward and circadian systems.

1.3.2 Diurnal variation in mesolimbic dopaminergic activity and other neurotransmitters
Diurnal rhythms in different behavioural responses to rewarding stimuli suggest
that circadian regulation exists at multiple levels of the mesolimbic reward system.
Given the central role of dopamine within this system, researchers have initially focused
on the activity of this neurotransmitter, with reports of daily rhythms in the
concentrations of extracellular dopamine and markers of dopaminergic activity.
Specifically, dopamine concentration in dialysate from the nucleus accumbens and
striatum peak during the active phase, as does the dopamine precursor 3,4dihydroxyphenylalanine (DOPA), and metabolites of dopamine, 3,4Dihydroxyphenylacetic acid (DOPAC) and homonovanillic acid (Castaneda, de Prado,
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Prieto, & Mora, 2004; Paulson & Robinson, 1996; Schade et al., 1993; Shieh, Chu, & Pan,
1997). Similarly, markers of dopamine activity, such as the concentration of tyrosine
hydroxylase (TH), the rate limiting enzyme in dopamine synthesis (Sleipness, Sorg, &
Jansen, 2007), the concentration and activity of the dopamine transporter (DAT), which
regulates dopamine clearance from the synapse (Sleipness, Jansen, Schenk, & Sorg, 2008;
Sleipness, et al., 2007), and dopamine D2 receptor function (Tonissaar, Herm, Rinken, &
Harro, 2006), are also rhythmic in PFC or NAc dialysate, with peaks during the dark
phase. Concentrations of dopamine D2 and D3 receptors also vary diurnally in the
striatum but instead peak during the late light phase (Akhisaroglu, Kurtuncu, Manev, &
Uz, 2005).

Dopaminergic inputs to the prefrontal cortex and striatum originate in the VTA,
making it a likely candidate to drive the observed rhythms in upstream brain regions, yet
little is known in regards to molecular rhythms in this region. A group of researchers
have recently reported diurnal rhythms in the neural impulse activity of a newly
discovered population of neurons in the VTA (Luo & Aston-Jones, 2009a; Luo, Georges,
& Aston-Jones, 2008). These neurons, which fire selectively during the active-phase, are
non-dopaminergic, and express a vesicular glutamate transporter, suggesting that they are
glutamatergic. Diurnal rhythms have also been reported in the activity of other
prominent neurotransmitters in these areas, but not as extensively as those of dopamine.
For instance, daily variations in glutamate, GABA, cholecystokinin, and the serotonin
metabolite 5-HIAA have been detected in the rat NAc (Castaneda, et al., 2004; Schade, et
al., 1993). These results, taken together, suggest that diurnal rhythms in dopaminergic
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and non-dopaminergic activity at multiple levels of the mesolimbic reward system may
contribute to daily variations in reward. However, experimental manipulations are
needed to directly evaluate this hypothesis.

1.3.3 Rhythmic clock gene expression in the mesolimbic reward system
The observed rhythms in reward and mesolimbic neurophysiology, if circadian in
nature, may be mediated by intrinsic localized clock gene oscillations or, alternatively,
may be conferred by neural projections or humoral output from the master clock. Selfsustaining clock gene oscillations are common to many mammalian bodily tissues
(Dibner, et al., 2010; Guilding & Piggins, 2007; Yoo et al., 2004), where they regulate
rhythms in cellular activity and physiology independently of the SCN while using many
of the same molecular components (Dardente & Cermakian, 2007). Equally, core
circadian clock genes (Reppert & Weaver, 2002) are expressed in mesolimbic structures
and, in some instances, are rhythmic. Time-of-day differences in Per(1&2) expression
have been reported for the PFC, NAc, striatum, VTA, amygdala, and hippocampus
(Iijima, Nikaido, Akiyama, Moriya, & Shibata, 2002; Li, Liu, Jiang, & Lu, 2009; Uz,
Akhisaroglu, Ahmed, & Manev, 2003). Peaks in clock gene expression generally occur
during the mid-to-late dark phase throughout the reward system with a few exceptions
during the mid light phase; such as per1 in the NAc core, the central amygdala (CeA),
and the VTA; and per2 in the mPFC, the amygdala and hippocampus.

The recent development of a transgenic mouse model expressing a
bioluminescent per1 gene has permitted the continuous monitoring of rhythms in clock
gene expression from isolated brain regions in vitro over many days, and thus facilitated
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the identification of self-sustaining extra-SCN oscillators. (Yamazaki et al., 2000).
Under these in vitro conditions, a rhythm in per1 bioluminescence was not observed in
the VTA and striatum (Abe et al., 2002), while the rhythm in striatal per2 quickly
dissipates after a few cycles (Natsubori, Honma, & Honma, 2012). It is unclear whether
the loss of bioluminescence rhythms in these brain areas is due the dependence on an
SCN entrainment signal or from being uncoupled from the reward network. In either
case, the lack of clock gene rhythms suggests that daily changes in electrical (Luo et al.,
2008; Luo and Aston-Jones, 2009), and dopaminergic activity (Castaneda, et al., 2004;
Schade, et al., 1993; Tonissaar, et al., 2006) are driven by a signal originating elsewhere.
The mPFC is a good candidate for driving rhythms in these arrhythmic reward areas as its
excitatory glutamatergic efferents modulate the activity in many reward-related brain
regions (Gabbott, Warner, Jays, Salway, & Busby, 2005), including the VTA and
striatum, it is involved in the execution of reward behaviour (Hyman, Malenka, & Nestler,
2006; Miller & Cohen, 2001; Ridderinkhof, van den Wildenberg, Segalowitz, & Carter,
2004; Rolls, 2004), and exhibits rhythms in clock gene expression (Li, et al., 2009) and
mesolimbic dopamine activity (Sleipness, et al., 2008). However, the role of the mPFC
in the regulation of reward rhythms has yet to be examined.

The specific phase relationship between oscillations in clock gene expression and
their protein products are critical to maintain the molecular clock mechanism (Ko &
Takahashi, 2006). Though rhythms of clock gene expression have been examined in
various regions of the mesolimbic system, little is known in regards to their protein
products. However, diurnal rhythms in the number of cells that express
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immunoreactivity (IR) for Per1 and Per2 were reported in some reward related brain
regions; where the peaks in Per1-IR in the NAc shell, and in Per2-IR in the CeA was in
phase with those of gene expression; while those of Per1-IR in the PFC and Per2-IR in
the hippocampus had opposite phases (Amir, Harbour, & Robinson, 2006; AngelesCastellanos, Mendoza, & Escobar, 2007; Lamont, Robinson, Stewart, & Amir, 2005).
One group of researchers have reported daily differences in the concentrations of Per1
protein in the striatum that peaks in the early light phase of the light/dark cycle, and
approximately 16 hours after the peak in gene expression (Akhisaroglu, et al., 2004; Uz,
et al., 2003). As tissue was sampled from the entire striatum, these findings lack the
spatial resolution necessary to make meaningful hypotheses regarding a functional
relationship between rhythms in clock gene expression and mesolimbic activity.

In the master clock, clock proteins drive rhythms in clock gene expression by
regulating the binding of the transcription factor Clock to E-boxes in their promoter
regions (Ko & Takahashi, 2006; Reppert & Weaver, 2001). The promotor regions for
monoamine oxidase A (maoa), TH, and the dopamine transporter also contain E-box
elements (Hampp et al., 2008; Kawarai, Kawakami, Yamamura, & Nakamura, 1997;
Yoon & Chikaraishi, 1992), which suggests that clock genes may directly regulate
dopamine synthesis and metabolism. Indeed, Hampp et al. (2008) have reported that the
maoa promoter is regulated by clock genes in vitro and that MAOA is downregulated in
per2 mutant mice. In addition, Clock has been localized to VTA dopaminergic neurons
and mutations of this gene results in an overall increase in mesolimbic dopamine activity
and synthesis (Coque et al., 2011; McClung, Nestler, & Zachariou, 2005; Spencer et al.,
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2012). This includes increased VTA TH expression and phosphorylation, increased
firing rates of VTA dopaminergic neurons, decreased soma size of VTA dopamine
neurons, increased dopamine metabolites DOPAC and homovanillic acid in the dorsal
striatum, and increased D1 and D2 receptor expression in the dorsal striatum. Thus, there
appear to be direct links between circadian clock genes and mesolimbic dopaminergic
activity.

It remains to be determined if other prominent mesolimbic neurotransmitter also
express E-boxes in their promoter regions. However, there is some evidence for clock
gene regulation of glutamate signalling. For instance Per2 mutant mice exhibit altered
glutamate and dopamine activity, specifically a decrease in the expression of the
glutamate transporter EEAT, which increases extracellular glutamate, in the brain
(Hampp, et al., 2008). Furthermore, DNAzyme mediated cleavage of Per1 in mice
blocks morphine-induced increases in extracellular-regulated kinases (ERK) (Y. Liu et al.,
2007). ERK activation is important for glutamate and dopamine signalling and for
mediating the rewarding effects of cocaine (Valjent et al., 2000; Valjent et al., 2005).

1.3.4 Clock gene manipulation and reward processing
In addition to influencing dopaminergic and glutamatergic activity, studies with
clock gene knock out or mutant animals have linked these genes to the regulation of
reward. per1 knockout mice do not sensitize to repeated cocaine injections nor do they
show a cocaine-induced conditioned place preference response (Abarca, et al., 2002).
Similarly, DNAzyme mediated cleavage of per1 inhibits morphine-induced conditioned
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place preference when applied prior to conditioning but has no affect on recall (Y. Liu et
al., 2005), suggesting that Per1 may be important for the coding of learned reward
associations. By contrast, per2 mutants exhibit hypersensitization and exhibit a normal
place preference response to cocaine (Abarca et al., 2002). Clock mutant mice also show
an increased sensitivity to reward. These animals exhibit an elevated place preference to
cocaine, increased cocaine-self administration, an increased preference for sucrose, and
require lower currents to sustain electrical brain self stimulation (McClung et al., 2005;
Ozburn, Larson, Self, & McClung, 2012; Roybal et al., 2007). At present, it is unknown
if these multiple effects stem from a lack of clock gene expression in the mesolimbic
dopaminergic system or elsewhere, or if they are due to a pleiotropic effect. In any case,
the current body of data taken together strongly suggests that clock genes influence
reward and motivation, and may do so via a direct modulation of dopaminergic activity.

1.3.5 The role of the SCN in regulating reward rhythms
Many extra-SCN oscillators are capable of self-sustained rhythmic output,
however, these rhythms eventually dissipates in the absence of an entrainment signal
(Yamazaki, et al., 2000). Individual cells in many rhythmic tissues are robust oscillators
that sustain long-lasting circadian output in vitro (Nagoshi et al., 2004; Welsh, Yoo, Liu,
Takahashi, & Kay, 2004), but the degree to which tissues are able to maintain circadian
output independently of the SCN is positively correlated with the strength of coupling
between the individual cells (Dibner, et al., 2010; Guilding & Piggins, 2007; Welsh,
Takahashi, & Kay, 2010). Thus, the function of the SCN is to entrain rather than sustain
rhythms in extra-SCN oscillators (Nagoshi, et al., 2004). While intrinsic mesolimbic
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clock genes have been implicated in the regulation of reward activity, SCN lesions blunt
or eliminate rhythms in Per1 and Per2 gene and protein expression in the amygdala and
the bed nucleus of the stria terminalis (BNST), suggesting that the SCN also involved in
the regulation of reward rhythms (Amir, Lamont, Robinson, & Stewart, 2004; Iijima, et
al., 2002; Lamont, et al., 2005).

Two possible pathways have been suggested for SCN-entrainment of the
mesolimbic system, however, the degree to which these pathways contribute to
rhythmicity remains to be determined. The first, an indirect projection from the SCN to
the VTA via the medial preoptic nucleus (Luo & Aston-Jones, 2009b). The second from
the SCN to the VTA via lateral hypothalamic orexin neurons (Deurveilher & Semba,
2005; Korotkova, Sergeeva, Eriksson, Haas, & Brown, 2003). This second pathway is
currently more promising as orexin neurons are known to be important for rewardinduced behavioural and molecular responses (Aston-Jones, Smith, Moorman, &
Richardson, 2009; Borgland, Taha, Sarti, Fields, & Bonci, 2006; Harris, Wimmer, &
Aston-Jones, 2005; H. Zheng, Patterson, & Berthoud, 2007). Furthermore, there have
been reports of SCN-dependent, diurnal rhythms in orexin cell activation and orexin
release into the VTA (Akiyama et al., 2004; Estabrooke et al., 2001; Lee, Hassani, &
Jones, 2005; Marston et al., 2008; Moorman & Aston-Jones, 2010; Zhang et al., 2004).
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1.4 THESIS RATIONALE AND OBJECTIVES
1.4.1 Rationale
Time-of-day difference have been reported in behavioural responses to drugs of
abuse, including self-administration (Baird & Gauvin, 2000), conditioned place
preference (Kurtuncu, et al., 2004), behavioural sensitization (Akhisaroglu, et al., 2004),
and drug induced locomotor activity, while diurnal changes in behavioural responses to
natural reinforcers have yet to be characterized. A growing body of evidence suggests
that rhythms in reward are controlled at the level of the mesolimbic reward system, as
time-of-day differences have been reported for markers of dopamine, glutamate, and
GABA signalling within areas of this system (Castaneda, et al., 2004; Luo, et al., 2008;
Sleipness, et al., 2008). The precise mechanism that mediates rhythms in reward requires
further elucidation, as does the nature of the timing signal that drives these rhythms.
Tissues level quantification of gene expression has revealed that clock genes are rhythmic
within the mesolimbic system (Iijima, et al., 2002; Li, et al., 2009; Uz, et al., 2003) and
are important for normal reward behaviour and mesolimbic activities (McClung,
Sidiropoulou, et al., 2005; Ozburn, et al., 2012). Moreover, their protein products can
bind to the promoter regions of genes involved in the synthesis and metabolism of
dopamine (Hampp, et al., 2008), however, daily oscillations of clock gene proteins have
yet to be characterized. Clock gene rhythms are not ubiquitous to all mesolimbic areas
that express oscillations in neural activity (Abe, et al., 2002), and may be driven by a
timing signal originating elsewhere. The role of the master clock is to entrain extra-SCN
oscillators (Nagoshi, et al., 2004; Welsh, et al., 2010), and surely two putative
entrainment pathways have been identified (Deurveilher & Semba, 2005; Korotkova, et
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al., 2003; Luo & Aston-Jones, 2009a), however, rhythms in reward can persist in the
absence of an SCN timing signal (Iijima, et al., 2002; Sleipness, et al., 2007), which
suggests that the mesolimbic system is intrinsically rhythmic. The mPFC is a potential
candidate for regulating rhythms in reward, as it is important for regulation of reward
(Hyman, et al., 2006; Miller & Cohen, 2001; Ridderinkhof, et al., 2004; Rolls, 2004),
exhibits rhythms in clock gene (Angeles-Castellanos, et al., 2007; Li, et al., 2009) and
dopamine activity (Castaneda, et al., 2004), and its excitatory glutamatergic efferents
innervate other rhythmic mesolimbic areas (Gabbott, et al., 2005).

1.4.2 Hypothesis
Behavioural responses to drugs of abuse and natural rewards are dependent on the
time of day. These daily differences reflect rhythms in the reward system, specifically in
mesolimbic activity and clock gene expression. The prefrontal cortex plays an important
role in orchestrating the timing of rhythms in reward and mesolimbic activity.

1.4.3 Objectives
1. To characterize diurnal and circadian rhythms in amphetamine and sex reward
using the conditioned place preference paradigm (Chapter 2).
2. To characterize diurnal rhythms in protein markers of dopamine synthesis, and
clock gene expression in the mesolimbic reward system (Chapter 2)

.

3. To characterize diurnal rhythms in cFos immunoreactivity in reward-related brain
regions (Chapter 3).
4. To demonstrate the role of the prefrontal cortex in modulating rhythms in
mesolimbic cFos immunoreactivity (Chapter 3).
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5. To demonstrate the role of the prefrontal cortex in modulating rhythms in
amphetamine conditioned place preference (Chapter 4).
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CHAPTER 2:
Diurnal Variations in Natural and Drug Reward, Mesolimbic Tyrosine Hydroxylase
and Clock Gene Expression in the Male Rat1

1

Research Article: Ricardo M Baltazar, Ian C Webb, Xu Wang, Lique M Coolen and
Michael N Lehman (2009). Journal of Biological Rhythms: 24 (6), 465-76.
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2.1 INTRODUCTION
Convergent evidence indicates that the hypothalamic suprachiasmatic nucleus
(SCN) is the locus of the master circadian pacemaker controlling daily rhythms in
physiology and behaviour (Moore, 1983; Moore & Eichler, 1972; Ralph, Foster, Davis,
& Menaker, 1990). This endogenous clock is primarily synchronized to the
environmental light/dark cycle via photic stimulation and entrains the internal milieu to
the external twenty-four hour world (Klein, Moore, & Reppert, 1991). The circadian
clock mechanism is thought to be comprised of transcriptional/translational feedback
loops that result in the rhythmic expression of core clock genes (e.g., period1, clock,
bmal1) and their protein products with a periodicity of about 24h (Ko & Takahashi, 2006;
Reppert & Weaver, 2002). Although clock genes are rhythmically expressed at extraSCN brain regions and in peripheral organs, the phase relationships between these central
and peripheral oscillators appear to be maintained by the SCN (Yoo et al., 2004).

The influence of the circadian timing system is ubiquitous and recent evidence
suggests a diurnal or a circadian modulation of reward and motivation. Rodents have
been reported to self-administer drugs of abuse in a diurnal fashion (Baird & Gauvin,
2000; Brebner, Froestl, Andrews, Phelan, & Roberts, 1999; Gauvin et al., 1997; Roberts
& Andrews, 1997; Roberts, Brebner, Vincler, & Lynch, 2002) and daily rhythms have
been observed in psychomotor stimulant-induced conditioned place preference,
sensitization, and locomotor activation (Akhisaroglu, Ahmed, Kurtuncu, Manev, & Uz,
2004; Evans, Ghiselli, & Patton, 1973; Gaytan, Lewis, Swann, & Dafny, 1999; Gaytan,
Yang, Swann, & Dafny, 2000; Kuribara & Tadokoro, 1982; Kurtuncu, Arslan,
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Akhisaroglu, Manev, & Uz, 2004; Urba-Holmgren, Holmgren, & Aguiar, 1977; Uz,
Akhisaroglu, Ahmed, & Manev, 2003; Uz, Javaid, & Manev, 2002). However,
conflicting results have been reported and, in many cases, the diurnal variation appears
dose-dependent (Baird & Gauvin, 2000; Gaytan, Swann, & Dafny, 1998a, 1998b;
Roberts, et al., 2002). To build upon this body of evidence and to extend these
observations to more natural rewards, here we test the hypothesis that daily rhythms exist
in the rewarding value of natural stimuli (i.e., sex) and that these may differ from those
related to drugs of abuse. We also examine diurnal variation in the locomotor activating
effect of acute systemic amphetamine administration.

The mechanisms responsible for rhythmic drug responsiveness are not entirely
clear. However, as reward processing is largely mediated by the mesolimbic
dopaminergic pathway connecting the midbrain with limbic forebrain areas (Hyman,
Malenka, & Nestler, 2006; Kelley, 2004; Kelley & Berridge, 2002), regulation likely
occurs at the level of this system. Indeed, daily rhythmic electrical activity and c-fos
expression have been detected in neural subpopulations within the nucleus accumbens
(NAc) and the ventral tegmental area (Angeles-Castellanos, Mendoza, & Escobar, 2007;
Luo, Georges, & Aston-Jones, 2008; Yamazaki, Kerbeshian, Hocker, Block, & Menaker,
1998), and virtually all indices of NAc dopaminergic activity exhibit a diurnal rhythm
(Castaneda, de Prado, Prieto, & Mora, 2004; Shieh, Chu, & Pan, 1997; Sleipness, Sorg,
& Jansen, 2007b; Tonissaar, Herm, Rinken, & Harro, 2006). The observed rhythms in
reward and dopaminergic activity, if circadian in nature, may be mediated by intrinsic
clock gene oscillations within the mesolimbic system, or, alternatively, may be conferred
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by neural projections or humoral output from other rhythmic structures including the
SCN. Thus, to further explore potential mechanisms underlying natural or drug reward
rhythms, daily variations in tyrosine hydroxylase (TH; the rate limiting enzyme in
dopamine synthesis) and core clock protein levels were examined in both the NAc and
the VTA, central components of the mesolimbic reward system.

2.2 METHODS
2.2.1 Animals
Young adult male Sprague-Dawley rats (300-400g, Charles River Laboratories, QC,
CAN) were singly housed in clear plexiglass cages under a 12:12 light/dark cycle
(~350lux L/0 lux D) with food and water available ad libitum. A minimum of two weeks
prior to any experimental procedures were allotted to allow for stable entrainment. To
facilitate testing during the dark phase of the LD cycle, red lights (~10-15 lux) were
employed during transport of the animals to the testing room and over the course of the
manipulations. All experiments were approved by the University of Western Ontario
Animal Care Committee and are in accordance with the guidelines set out by the
Canadian Council on Animal Care.

2.2.2 Drugs
D-amphetamine sulphate (Sigma-Aldrich Ltd. ON, Canada) was dissolved in
sterile saline, calculated based upon the free base, and administered in a volume of
1mL/kg body weight.
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2.2.3 Conditioned Place Preference Testing
Apparatus
The conditioned place preference (CPP) apparatus (Med Associates Inc., VT,
USA) consisted of two distinct plexiglass chambers (28 L x 21 W x 21 H cm) connected
by a narrow hallway (12 L x 22 W x 21 H cm) via sliding doors. One chamber had black
walls with a floor consisting of parallel steel bars, the other had white walls with a metal
grid floor, and the connecting hallway had grey walls with a flat plexiglass grey floor.
All compartments were covered with a clear ventilated ceiling that was hinged and could
be opened to move animals in and out or locked to prevent escape. The time spent within
each chamber was monitored by an array of infrared beams and was recorded via Med
PC software (Med Associates Inc.). The chambers were cleaned thoroughly with a
solution of 70% ethanol to ensure that they remained olfactory neutral following each
trial. To minimize the potential for photophobic responses during the light phase of the
LD cycle, the CPP apparatus was positioned to equalize light intensity across the
chambers.

General Procedure
CPP testing consisted of three phases taking place over four days. During the preconditioning phase, performed on day 1, rats were placed in the central hallway and
allowed free access to the entire apparatus for 15 minutes. The chamber in which the
animal spent most time was designated the initially preferred chamber. Any animal
spending more than twice as much time in one chamber as compared to the other was
considered an outlier and excluded from the study (2 % of all animals). To facilitate
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comparisons with previous work, a biased design was used for the sex reward
experiments (Pfaus, Kippin, & Centeno, 2001; Tenk, Wilson, Zhang, Pitchers, & Coolen,
2009), while an unbiased approach was used for the drug reward studies (Tzschentke,
1998, 2007). With a biased design, conditioning assignments were organized such that
the reward was paired with the initially non-preferred chamber. For the unbiased
approach, half of the animals had the reward paired with the initially preferred chamber
and half with the initially non-preferred chamber. To minimize any potential entrainment
to the reward, conditioning took place over two days with only one reward pairing. On
one of the conditioning days, the animals received the reward and were confined to one
of the chambers for 30 min. On the alternate day, the animals did not receive the reward
and were placed in the opposite chamber, again for 30 min. These manipulations were
performed in counterbalanced order across animals. On day 4, the animals were retested
for chamber preference, as in the pre-conditioning phase.

Each animal was conditioned and tested at only one of four zeitgeber times (ZT):
ZT05, ZT11, ZT17 or ZT23, where, by convention, ZT12 corresponds to lights off. To
rule out a change in preference due to habituation alone, control animals which did not
receive the reward on either of the conditioning days, were included for each experiment
and were tested at one time point.

The change in chamber preference was expressed as the time spent in the rewardpaired chamber post-conditioning minus pre-conditioning. To determine the extent of
reward conditioning and to identify any diurnal variation, the change in chamber
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preference at each time point was compared both to the negative control and to all other
time points via unpaired t-tests.

2.2.4 Open Field Apparatus
Horizontal locomotor activity was assessed via a plexiglass open field activity
chamber (43.2 x 43.2 cm; Med Associates Inc.) equipped with a 16 x 16 infrared beam
array to monitor the animal’s movement. The chamber was wiped with 70% alcohol and
lined with fresh corn cob bedding prior to each trial.

2.2.5 Experiment 1: Diurnal and circadian variation in male sexual performance and sexrelated reward
Sexual Experience
To ensure adequate performance during the conditioning stage, while at the same
time preventing potential entrainment to the reward, sexually naïve male rats (n = 37)
were given eight bouts of sexual experience (2 sessions/wk over a 4 wk period);
randomized over four different time points (for half the animals, n = 20: ZT04, 10, 14, or
23 and for the other half, n = 17: ZT02, 11, 13, or 22). During each trial, males received
a sexually receptive female in the home cage. These young sexually experienced adult
females were ovariectomized and implanted with subcutaneous silastic capsules (1.98
mm inner diameter, 0.5 cm length, Dow Corning Corp., MI, USA) containing 5% 17-βestradiol benzoate (Sigma-Aldrich Ltd., ON, CAN). To induce sexual receptivity, 500 µg
progesterone (Sigma-Aldrich Ltd., ON, CAN) dissolved in 0.1 ml of sesame oil was
administered s.c. 4 hours prior to the mating sessions. The males were allowed to mate
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until either the first post-ejaculatory intromission or until one hour had elapsed. To
assess any temporal variations in sexual performance, the percentage of animals
ejaculating and the latency to ejaculation were recorded and compared across time points.
Daily variation in the percentage of ejaculation and latency to ejaculations were assessed
via Fisher’s exact test or Kruskal-Wallis ANOVA followed by Dunn’s multiple
comparison tests, respectively.

Experimental Protocol
The conditioning trials were carried out using a biased design as described above.
On one of the conditioning days, the males received a receptive female in the home cage
and, immediately following ejaculation, were placed in the sex-paired chamber. On the
alternate day, males were removed from their homecages and placed into the opposite
chamber. Animals that failed to ejaculate within one hour were removed from the study
leaving 6-7 animals per time point (ZT5, n= 7; ZT11, n = 6; ZT17, n = 7; ZT23, n = 6).
A control group (n = 12) consisting of males that did not receive sex on either
conditioning day also was included at ZT17. This time point was selected post-hoc to
coincide with the observed peak in sexual reward.

To determine if the observed diurnal variation was circadian in nature, a separate
group of sexually naive males was housed under constant darkness and tested at
approximately circadian time (CT) 05 (n = 10) and 17 (n = 10). As circadian phase is
difficult to assess from rat locomotor activity rhythms measured via telemetry and wheelrunning associated reward (Lett et al. 2000; 2001) may have influenced our results, the
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males were placed into darkness for only two days prior to testing under the assumption
that their internal phase would not drift significantly within that time. Thus, CT was
estimated in reference to the light-dark schedule prior to being placed into constant
conditions.

2.2.6 Experiment 2: Diurnal variation in amphetamine-related reward
To prevent injection related anxiety during conditioning, rats received sterile
saline (1 ml/kg, s.c.) on three consecutive days prior to testing. On one of the
conditioning days, the animals received amphetamine (1.75 or 2.5 mg/kg, s.c.) and were
confined to the drug-paired chamber. On the alternate conditioning day, the rats received
saline (1 ml/kg, s.c.) and were placed in the non-paired chamber. At both the lower dose
(n = 12 per time point) and the higher dose (n = 24 per time point except at ZT23 where n
= 23), conditioning assignments were carried out in an unbiased fashion. A control group
(n = 12) of animals receiving saline on both conditioning days was run at ZT23, a timepoint chosen post-hoc to coincide with the observed peak in 2.5 mg/kg amphetamine
reward.

2.2.7 Experiment 3: Diurnal variation in amphetamine-induced locomotor activity
To determine if amphetamine-induced locomotion varied by time-of-day, male
rats were tested at one of four times (ZT05, ZT11, ZT17 or ZT23; n = 8 per time point).
Horizontal locomotor activity was first recorded following saline injections (1 ml/kg, s.c.,
at the same time as the test for amphetamine) on three consecutive days. On the fourth
day, each animal received amphetamine (1 mg/kg, s.c.). Immediately following each
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injection, the animals were placed into the open field apparatus for 1 h. Data were
analyzed by conventional or Kruskal-Wallis ANOVA followed by Bonferroni
comparisons or Dunn’s multiple comparison tests where appropriate.

2.2.8 Experiment 4: Diurnal variation in mesolimbic TH and clock gene protein levels
Tissue Collection and Protein Isolation
Rats were euthanized with sodium pentobarbital (125 mg/kg, i.p.) at 6 different
time points (ZT02, 06, 10, 14, 18, and 22; n = 8 per time point). Brains were rapidly
removed, frozen on dry ice, and stored at -80°C until processing. The VTA, the NAc, and
the SCN were microdissected and homogenized mechanically in RIPA buffer (50mM
Tris-HCL; 150mM NaCL; 1% Nonidet P 40; 0.1% sodium dodecyl sulphate [SDS]; 0.5%
sodium deoxycholate) supplemented with a protease inhibitor cocktail tablet (HoffmanLa Roche Ltd., ON, CAN.). The homogenization mixture was centrifuged at 12,000 rpm
for 20 min at 4°C and the supernatant collected. Protein concentrations were determined
using a BCA assay (ThermoFisher Scientific Inc., MA, USA) and a NanoDrop ND-1000
spectrophotometer (ThermoFisher Scientific Inc., MA, USA).

Western Blot Analysis
Protein samples of equal volume (15µL) and concentration (10µg/µL) were boiled
at 96ºC for 4 min using an AccuBlock Digital Dry Bath (Labnet International, NJ, USA)
and cooled on ice prior to loading on a 10% polyacrylamide gel and separation under
reducing conditions using a Mini Trans-Blot Cell system (Bio-Rad Laboratories Ltd.,
ON, CAN) and Tris-Glycine-SDS running buffer (25mM Tris; 192mM Glycine; 0.1%
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w/v SDS, pH 8.3; Bio-Rad Laboratories Ltd.). Precision Plus Protein All Blue Standards
(Bio-Rad Laboratories Ltd., ON, CAN) were used as molecular weight markers. All
samples were run in quadruplicate and balanced by time point across the individual gels.

Following separation, the proteins were transferred to Millipore Immobilon-FL
polyvinylidene difluoride membranes (Millipore, MA, USA) using the Mini Trans-Blot
Cell wet blotting system (Bio-Rad Laboratories Ltd., ON, CAN). The membrane transfer
was run in transfer buffer [10% methanol in Tris-Glycine (25mM Tris; 192mM Glycine
pH 8.3), Bio-Rad Laboratories Ltd., ON, CAN] at 85V for 1 h at room temperature (RT).

Next, the membranes were blocked in a 2:3 solution of Odyssey Blocking Buffer
(OBB; LI-COR Biosciences, NE, USA) and Tris-Buffered Saline (TBS; 50mM Tris and
150mM NaCl, pH 8.0) for 40 min on a shaker tray at RT. Samples were then
individually incubated for 16 h on a shaker at 4ºC with goat anti-Period1 (1:4,000,
custom made by Bethyl Laboratories, Inc., TX, USA) or rabbit anti-Bmal1 (1:200,
Affinity BioReagents, CO, USA). All blots were also simultaneously incubated with
mouse anti-TH (1:200,000, Chemicon International, CA, USA) and mouse anti-GAPDH
(1:200,000; Chemicon International), the latter of which was used as a loading control.
All antibodies were diluted in 2:3 mix of OBB with TBS-T (TBS + 0.05% v/v Tween-20,
pH 8.0). Following three 10 min washes in TBS-T, the membranes were incubated in
secondary antibodies diluted in a 2:3 mix of OBB and TBS-T for 1 h at RT. The
secondary antibodies used included Alexa-680 conjugated donkey anti-goat (1:5000;
Invitrogen, CA, USA), Alexa-680 conjugated goat anti-rabbit (1:5000, Invitrogen), IR-
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Dye 800 conjugated goat anti-mouse (1:10,000, Rockland, PA, USA), and IR Dye 800
CW conjugated goat anti-mouse (1:10,000; LI-COR Biosciences). Bands of
immunoreactivity were visualized and images captured using an Odyssey 2.1 scanner
(LI-COR Biosciences). Ratios of protein/GAPDH intensity levels were determined for
each protein sample and averages calculated for each animal. Ratios for each animal
were normalized to the overall mean for all time points and thus expressed as fold
changes over the mean expression across the day. Data were analyzed by conventional or
Kruskal-Wallis ANOVA followed by t-tests, Bonferroni comparisons or Dunn’s multiple
comparison tests where appropriate.

All antibodies resulted in single bands of immunoreactivity, except for Period1,
which labelled multiple bands (see results section) similar to those described previously
for the mouse (Chilov, Hofer, Bauer, Wenger, & Gassmann, 2001). Specificity of the
Period1 and Bmal1 antibodies was demonstrated by a complete loss of immunoreactivity
following preabsorption with the immunizing peptides (1 and 10ug/mL) overnight at 4˚C
prior to incubation with the membrane.

2.3 RESULTS
2.3.1 Experiment 1: Diurnal and circadian variation in sexual performance and sexrelated reward
During the training period, measures of sexual performance varied with a diurnal
pattern. The percentage of animals that ejaculated during the mid-night to the mid-day
(ZT14 – ZT04; p < 0.0001 - 0.022) was significantly higher as compared to time points
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surrounding the light-to-dark transition; (ZT11 - ZT13; Fig. 1A). The latency to first
ejaculation also varied diurnally (p < 0.001) with significantly longer latencies observed
near the light-to-dark transition (ZT11-ZT13) as compared to other time points (ZT02,
ZT04, ZT22 and ZT23; p < 0.001-0.05; Fig. 1B).

The ejaculation-induced change in preference also varied by time-of-day as rats
spent significantly more time in the sex-paired chamber only at ZT17 as compared to the
no sex control animals (p = 0.006; Fig. 1C). In addition, the change in preference was
significantly higher at ZT17 as compared to ZT05 (p = 0.050). This daily variation
remained under constant conditions (CT17 vs. CT05; p = 0.046) suggesting that the daily
rhythm in sex-related reward may be circadian in nature.
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Figure 1 – Diurnal variation in sexual behaviour and sex-related reward in the male
rat. A. The percentage of male rats that ejaculated during training at different time
points. B. The mean latency to first ejaculation during training at different time points. C.
The change in chamber preference induced by ejaculation under a 12:12 light:dark cycle
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and under constant darkness. A no sex negative control was performed at ZT16. Data are
expressed as mean ± SEM. The non-shaded and shaded areas correspond light and dark,
respectively. Bars with different letters are significantly different and the * denotes a
significant difference between the labelled bar and the no sex control, ZT05 or CT05.
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2.3.2 Experiment 2: Diurnal variation in amphetamine-induced reward
At all time points, 1.75 mg/kg amphetamine did not induce a significant change in
chamber preference as compared to the saline negative control and the magnitude of the
change in preference did not vary across time points (Fig. 2). However, at 2.5 mg/kg,
amphetamine induced a significant change in preference at ZT05 (p = 0.007), ZT17 (p =
0.026) and ZT23 (p = 0.011) relative to saline control group. Comparisons across the
time points revealed that the change in preference was significantly higher at ZT05 (p <
0.001), ZT17 (p = 0.003) and ZT23 (p < 0.001) as compared to ZT11.
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Figure 2 – Diurnal variation in the conditioned place preference induced by two
systemic doses of amphetamine. Data are expressed as mean ± SEM. * = significantly
different from ZT11 and the saline control at 2.5 mg/kg dose.
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2.3.3 Experiment 3: Amphetamine-induced locomotor activity varies in a diurnal fashion
As expected, baseline locomotor activity following saline injections varied
diurnally (K = 11.0, p = 0.015) with significantly greater horizontal locomotion observed
during the mid-dark period as compared to the late-light period (ZT17 vs. ZT11, p =
0.015; Fig. 3A). The locomotor activity elicited by amphetamine also varied
significantly by time-of-day (F = 6.9, p = 0.001; Fig. 3B) with more ambulations
recorded at ZT23 as compared to all other time points (p < 0.050). As compared to the
saline control injections, the total horizontal distance travelled following amphetamine
administration was significantly higher at ZT05 (p = 0.003), ZT11 (p < 0.001), and ZT23
(p < 0.001). When subtracted from the saline baseline data, locomotor activity induced
by amphetamine varied significantly by time of day (F= 0.34, p = 0.008, Fig. 3C) and
post-hoc analysis revealed significantly higher activity at ZT23 as compared to ZT17 (p =
0.005; Fig. 3C).
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Figure 3 - Diurnal variation in the locomotor activating effect of acute amphetamine
(1 mg/kg) administration. A. Daily variation in baseline horizontal locomotor activity
following saline administration. B. Daily variation in horizontal locomotor activity
following amphetamine administration C. Daily variation in horizontal locomotor activity
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following amphetamine administration with the baseline saline data subtracted out. Data
is is expressed as mean ± SEM. * = significantly different from ZT11; # = significantly
different from all other time points; + = significantly different from ZT17.
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2.3.4 Experiment 4: Rhythmic TH and clock gene expression in the VTA, NAc and SCN
Although the overall ANOVA was non-significant, subsequent post-hoc analysis
revealed that VTA TH protein levels were significantly higher at ZT6 as compared to
ZT10 (p = 0.010), 14 (p = 0.005), and 18 (p = 0.024; Fig. 4A). However, neither Period1
(~100 kDa; ~80 kDa; ~45 kDa; Fig. 5A-C) or Bmal1 (Fig. 5D) varied significantly across
the day in this region. Within the NAc, TH protein levels also varied in a diurnal fashion
(F = 2.9, p = 0.023; Fig. 4B) and were significantly higher at ZT14 as compared to ZT06
(p = 0.011). The NAc Period1 ~45 kDa band showed a daily rhythm as well (F = 2.8, p =
0.036) with increased levels observed at ZT22 as compared to ZT02 (p = 0.027, Fig. 5G).
However, the ~150 kDa (Fig. 5E) and ~100 kDa (Fig. 5F) bands did not show a
significant variation across the day. NAc Bmal1 protein levels also varied diurnally (K =
24.6, p < 0.001; Fig. 5H) with increased expression observed at ZT22 (p < 0.001) and
ZT18 (p < 0.001) as compared to ZT02, and at ZT18 as compared to ZT06 (p < 0.001).
As expected, rhythmicity was detected in the SCN Per1 ~100 kDa band (F = 3.9, p =
0.009; Fig. 5J) with protein levels significantly higher at ZT02 (p = 0.035) and ZT14 (p =
0.011) as compared to ZT06. By contrast, the SCN ~45 kDa Period1 band (Fig. 5K) and
Bmal1 (Fig. 5L) did not vary significantly across the day.
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Figure 4 – Diurnal variation in tyrosine hydroxylase (TH) expression in the reward
system. Shown are the fold change in the ratios of TH to GAPDH relative to the overall
mean of all time points in the A. ventral tegmental area (VTA; * = significantly different
from ZT10-18) and B. the nucleus accumbens (NAc; * = significantly different from
ZT6). Data are expressed as mean ± SEM..
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Figure 5 – Diurnal variation in clock gene expression in the reward system and in
the suprachiasmatic nucleus (SCN). Shown are the fold change in ratios of Period1 and
Bmal1 to GAPDH relative to the overall mean for all time points in the ventral tegmental
area (VTA; 3 bands; ~100, 80, 45 kDa; A-D), the nucleus accumbens (NAc; 3 bands;
~150, 100, 45 kDa; E-H) and the SCN (I-L). Also shown are the western blots for
Period1, Bmal1, tyrosine hydroxylase (TH), and GAPDH (I). Protein standards (from top
to bottom): 150 kDa, 100 kDa, 75 kDa, 50 kDa, 37kDa, 25 kDa, 20kDa. Data is
expressed as mean ± SEM.
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2.4 DISCUSSION
We show here that mating and drug-related reward as assessed by conditioned
place preference vary in a diurnal fashion but exhibit a difference in timing relative to
each other, with the peak in sex reward occurring in the early night (ZT17) and maximal
amphetamine-related reward occurring both during the night and early day (ZT17-05)
with a nadir in the late day (ZT11). The differences in timing of peaks and nadirs
observed for these rewards are suggestive of modulation at multiple levels of the
mesolimbic reward system. Indeed, analyses of TH, Period1, and Bmal1 revealed a
differential temporal expression with cyclic expression of clock genes observed in the
NAc and TH rhythmicity seen in both the VTA and NAc. Interestingly, the rhythms of
TH expression in these areas were out of phase with each other, with the peak in sex
reward coinciding with increased NAc TH and the peak in amphetamine reward with
elevated VTA TH.

We speculate that the differences between these structures in their rhythms of
mesolimbic DA synthesis may contribute to the differences in timing observed between
sex and amphetamine-related reward. In the NAc, daily variation in TH protein levels as
well as other indices of DAergic activity (DOPA, and the DA metabolites HVA and
DOPAC) has been reported previously, with peaks occurring, as we observed for TH,
during the night (Castaneda, et al., 2004; O'Neill & Fillenz, 1985; Paulson & Robinson,
1996; Shieh, et al., 1997). Similar rhythms in the NAc also have been reported for DA
transporter protein levels (Sleipness et al., 2007b) and DA D2 receptor functioning
(Tonissaar, et al., 2006). Taken together, these observations suggest that endogenous DA
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release from dopaminergic terminals in the NAc is high during the night, corresponding
to the peak time of sex-related reward (Fig. 6). Thus, it appears that the reward system is
designed to maximize NAc DA release in response to natural rewards during the night,
when locomotor activity levels are high and when encounters with biologically relevant
stimuli (e.g., a sexually receptive female) are most likely to occur in the natural
environment. Conversely, the high levels of TH protein seen during the daytime in the
VTA may reflect increased somatodendritic release of DA and inhibition of VTA DA
neurons via the activation of D2 receptors (Adell & Artigas, 2004). The timing of peak
amphetamine-induced reward therefore occurs when inhibition of VTA dopamine
neurons is high, and TH and DA in the NAc are intermediate to low. Thus,
amphetamine, and perhaps other drugs of abuse, appear most rewarding at times when
the propensity for evoked NAc DA release is relatively low.
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Figure 6 – A schematic overview of phase relationships between the rhythms in sex
and amphetamine-related reward and tyrosine hydroxylase (TH) expression in the
nucleus accumbens (NAc) and the ventral tegmental area (VTA). The circles
highlight overlapping peaks and nadirs between reward rhythms and mesolimbic TH
protein levels.
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It is important to note, however, that TH expression may be altered by reward
presentation. Indeed, there is data to suggest that drugs of abuse may induce TH
expression in reward-related areas (Ferrari, Le Novere, Picciotto, Changeux, & Zoli,
2002). However, to our knowledge, there is no data regarding the influence of sexual
experience or drug administration on mesolimbic TH rhythms. As well, the affinity of
TH for its substrate is regulated by phosphorylation and TH protein levels may not
accurately reflect the activity of this enzyme. Further study will be needed to address
these issues and to evaluate the hypothesized causal links based upon the current
correlational data.

Rhythmic clock gene expression in the NAc also may contribute to the diurnal
variation in reward via a direct modulation of DA synthesis. Clock genes have the
potential to directly regulate dopamine synthesis and metabolism as the promotor regions
for monoamine oxidase A (maoa), TH, and the dopamine transporter all contain E-box
elements (Hampp et al., 2008; Kawarai, Kawakami, Yamamura, & Nakamura, 1997;
Yoon & Chikaraishi, 1992). Supporting this possibility, Hampp et al. (2008) reported that
the maoa promoter is regulated by clock genes in vitro and that MAOA is downregulated
in period2 mutant mice. Other work utilizing clock mutant mice has indicated increased
levels of TH protein in the VTA of these animals (McClung et al., 2005). Studies with
clock gene knock out or mutant mice also suggest that these genes regulate reward
processing, although such regulation appears complex. For instance, period1 knockout
mice do not sensitize to repeated cocaine injections or develop a cocaine-induced
conditioned place preference while period2 mutants show hypersensitization and a
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normal place preference to cocaine (Abarca et al., 2002). As well, clock mutant mice
exhibit increased firing of VTA dopaminergic neurons, increased cocaine-induced place
preference, and require lower currents to sustain intracranial self stimulation (McClung,
et al., 2005; Roybal et al., 2007). Thus, the current body of data support the view that
clock genes can influence reward and motivation, and may do so, in part, via a direct
modulation of dopaminergic activity, in particular, at the level of the NAc.

As clock genes may contribute to the expression of rhythms not only via signals
from the SCN but also by intrinsic rhythmicity in extra-SCN brain areas and in peripheral
tissues (Yoo et al., 2004), it may be that the observed diurnal rhythmicity in reward and
TH expression stems from clock gene oscillations within structures of the reward system.
Indeed, many of the core circadian clock genes have been localized to reward-related
areas and have been reported to oscillate in these structures (Amir, Harbour, & Robinson,
2006; Angeles-Castellanos, et al., 2007; Feillet, Mendoza, Albrecht, Pevet, & Challet,
2008; Lamont, Robinson, Stewart, & Amir, 2005; McClung, et al., 2005; Verwey, Khoja,
Stewart, & Amir, 2007). The current results confirm that period1 and bmal1 are
expressed in both the NAc and the VTA, and, in the case of the NAc, the expression
appears rhythmic in nature. Thus, the observed rhythmicity in NAc TH expression, and
the previously reported circadian rhythm in NAc electrical activity (Yamazaki, et al.,
1998) may be mediated in part by local rhythmic clock gene expression. By contrast, the
apparent lack of clock gene rhythmicity in the VTA suggests that the diurnal variation in
TH expression and the previously described rhythm in VTA electrical activity (Luo, et
al., 2008) are driven by an extra-VTA signal, perhaps via an indirect projection from the
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SCN (Luo & Aston-Jones, 2009). One caveat regarding this interpretation is that the
VTA is a heterogeneous population comprised of both DA and non-DA cells (Fields,
Hjelmstad, Margolis, & Nicola, 2007), and it may be that only specific cell types in the
VTA rhythmically express clock genes. In this case, sampling from the entire VTA cell
population may mask any intrinsic rhythmicity in a specific subpopulation. Cell typespecific analyses of clock gene expression in the VTA, as well as the NAc, would be
desirable to address this issue.

Given that the development of a conditioned place preference is dependent upon
associative learning processes, the daily variation seen in this response could potentially
be due to a rhythm in the propensity for learning. If this is true then one would predict
that a CPP response would vary in a similar fashion across the day regardless of the type
of reward presented. The current results indicate that there are differential rhythms for
sex and amphetamine related reward, thus suggesting that the diurnal variation is due to a
rhythm in reward itself and not in the capacity for associative learning. It may also be
argued that the development of a “time-stamp”, the phenomenon where time-of-day is
encoded along with other contextual elements during memory formation (Cain, Ko,
Chalmers, & Ralph, 2004; Ralph et al., 2002), may have influenced our results. In the
current experiments, however, conditioning and testing occurred at the same time of day;
thus, any daily variation is not attributable to differences between testing and training
times. Moreover, the time stamp studies to date have utilized multiple conditioning trials
and it is unclear if the formation of a time-stamp occurs with a single reward pairing.
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Contrary to what one might expect, we also found interesting differences in the
timing of performance vs. reward with respect to both sex and amphetamine. In
agreement with previous work (Harlan, Shivers, Moss, Shryne, & Gorski, 1980), we
found that male rat sexual performance varies in a diurnal fashion with a nadir occurring
near the light-to-dark transition. By contrast, sex-induced reward peaks during the middark period and ebbs during the mid-day. The reasons for this difference in the timing of
peak sexual performance and reward are unknown but it seems reasonable to postulate
that reward need not be constantly elevated to sustain a previously reinforced behaviour.
Similarly, there is a difference between the timing of peak amphetamine-induced
locomotor activity and reward. At the higher dose, the reward induced by systemic
amphetamine administration also shows a robust rhythm with a nadir prior to dark onset
while amphetamine-induced locomotion peaks during the late dark period. Our findings
on the timing of amphetamine reward are consistent with prior work in rodents indicating
that cocaine-induced place preference is increased during the midday as compared to dark
onset or to the mid-dark period (Abarca, Albrecht, & Spanagel, 2002; Kurtuncu, et al.,
2004; Sleipness, Sorg, & Jansen, 2007a) and overall argue for separate mechanisms or
neural substrates underlying circadian regulation of performance vs. reward.

In conclusion, the current results demonstrate that the reward induced by both
natural stimuli and drugs of abuse varies in a diurnal fashion, further reinforcing the view
that time of day is a critical variable to consider when assessing appetitive or addictive
behaviour in the laboratory or clinical settings. As sex and amphetamine reward rhythms
differ in the precise timing of their peaks and nadirs, further work will be necessary to
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elucidate whether rhythms associated with other types of reward (e.g., palatable food)
correspond to either of these patterns. The current study, in conjunction with previous
work, suggests that daily variation in reward may be mediated by diurnal variations in
mesolimbic dopaminergic activity that are driven, in part, by local clock gene
oscillations. In particular, we suggest that the peak in sex reward occurs when the drive
for NAc DA release is at its highest while the peak in amphetamine-related reward
coincides with a lower likelihood of evoked NAc DA release. Further work will be
needed to test these hypotheses, however, and, given the anatomical and neurochemical
complexity of the mesolimbic reward system, it is likely that a diurnal and/or circadian
regulation occurs at multiple sites of action.
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CHAPTER 3:
Prefrontal Cortex Modulates Diurnal Rhythms in Neural Activation
in the Mesolimbic Dopamine System
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3.1 INTRODUCTION
Rewarding behaviours are largely mediated by the mesolimbic system
(Frohmader, Pitchers, Balfour, & Coolen, 2010; 2004), comprised of the ventral
tegmental area (VTA), nucleus accumbens (NAc), medial prefrontal cortex (mPFC),
amygdala, and other regions (Ikemoto, 2007; Spanagel & Weiss, 1999). Mesolimbic
brain areas are activated during natural reward behaviours (Martel & Fantino, 1996; Noel
& Wise, 1995) , including sexual behaviour (Balfour, Yu, & Coolen, 2004; Pfaus et al.,
1990; Pitchers et al., 2010), aggression (Wolf, Sun, Mangiavacchi, & Chao, 2004), and
maternal behaviour (Champagne et al., 2004; Numan et al., 2010); and in response to
conditioned cues predicting natural rewards (Balfour, et al., 2004), and drugs of abuse
(Di Chiara & Imperato, 1988; Thomas, Kalivas, & Shaham, 2008). A growing body of
work has revealed that many of the behavioural responses to rewarding stimuli vary
substantially over the course of a day. Conditioned place preference (CPP), locomotor
activation and sensitization in response to psychostimulants (Abarca, Albrecht, &
Spanagel, 2002; Kurtuncu, Arslan, Akhisaroglu, Manev, & Uz, 2004; Webb et al., 2009)
and natural rewards (Webb, Baltazar, Lehman, & Coolen, 2009; Webb, Baltazar, Wang,
et al., 2009) depend significantly on time-of-day. The mechanisms responsible for these
diurnal variations in motivation and reward remain to be fully elucidated, but there is
evidence for involvement of the mesolimbic system, and particularly of the
neurotransmitter dopamine. Markers of dopaminergic activity vary by time-of-day in the
VTA and NAc (Webb, Baltazar, Lehman, et al., 2009), including the expression of
tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis (Sleipness,
Sorg, & Jansen, 2007; Webb, Baltazar, Wang, et al., 2009), of dopamine transporters
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(Sleipness, et al., 2007), and of monoamine oxidase (Hampp et al., 2008), which breaks
down dopamine.

The first objective of this study was to characterize diurnal fluctuations in neural
activation throughout the mesolimbic system, using cFos protein expression as the
marker for neural activation. The use of cFos as a marker to elucidate diurnal rhythms in
neural activation is well documented for brain areas involved in sleep and wakefulness
(Basheer et al., 1997; Cirelli, Pompeiano, & Tononi, 1993; Grassi-Zucconi et al., 1993),
including activation of the orexin/hypocretin system (Estabrooke et al., 2001; Martinez,
Smale, & Nunez, 2002). Moreover, investigation of cFos protein expression during sleep
and wake states provided support for diurnal rhythms in neural activation in the
mesolimbic system (Pompeiano, Cirelli, & Tononi, 1994), specifically the mPFC and
NAc. However, a comprehensive characterization of neural activation in the mesolimbic
system across the day has yet to be conducted.

The second objective of this study was to test the hypothesis that the mPFC plays
a critical role in mediating the daily rhythms in neural activation in the mesolimbic
system. The mPFC provides a major source of glutamatergic inputs to the VTA and NAc
(Carr & Sesack, 1999, 2000; Omelchenko & Sesack, 2007), and glutamate receptor
activation has been implicated in induction of cFos expression (Rossetti, Marcangione, &
Wise, 1998; Vanhoutte et al., 1999; Xia, Dudek, Miranti, & Greenberg, 1996).
Therefore, the mPFC is a potential candidate for regulating diurnal rhythms in neural
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activity in its target areas. Together, these studies test the hypothesis that there are
diurnal variations in neural activity within the mesolimbic system.

3.2 METHODS
3.2.1 Animals
Adult male Sprague-Dawley rats (300-350g, Charles River Laboratories, QC,
CAN) were pair-housed in standard rat housing cages with ad libitum food and water.
The animals were placed under a 12:12 light/dark cycle (~350lux L/0 lux D) and were
allowed to acclimatize for 2 weeks prior to tissue collection. Rats for lesioned
experiments were allowed to acclimatize for 1 week prior to surgery and 2 weeks for
recovery and light cycle entrainment. All experiments were approved by the University
of Western Ontario Animal Care Committee and the University Committee on Use and
Care of Animals at the University of Michigan and are in compliance with the guidelines
of the Canadian Council on Animal Care and the United States National Institute of
Health.

3.2.2 cFos immunoreactivity analysis
Tissue Collection
At 6 different zeitgeber times (ZT 02, 06, 10, 14, 18, 22, n = 6-8 per time point,
where ZT12 corresponds to lights off by convention), rats were deeply anaesthetized with
sodium pentobarbital (270 mg/kg, i.p.) and perfused transcardially with 50 ml saline
followed by 500 ml 4% paraformaldehyde in 0.1M phosphate buffer (PB). Brains were
removed, post-fixed for one hour, and stored in 20% sucrose in 0.1M PB with 0.01%
sodium azide at 4°C until sectioning. For time points coinciding with the dark phase,
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tissue collection was performed under dim red light (~1 lux). Brains were sectioned with
a freezing microtome into four parallel series of 35µm coronal sections and stored in
cryopreservative (Watson, Wiegand, Clough, & Hoffman, 1986) at -20°C until
immunohistochemical processing.

Immunohistochemistry
All incubations and rinses were performed at room temperature on free floating
tissue via gentle agitation. Following each incubation, sections were rinsed thoroughly in
saline buffered sodium phosphate buffer (PBS, 0.1M, pH 7.4). Sections were incubated
for ten minutes in 1% H202 in 0.1M PBS and for one hour in incubation solution (0.1%
bovine serum albumin and 0.4% Triton X-100 (Fisher Scientific, Ottawa, Canada) in
PBS). One series of sections for each animal was incubated with a rabbit polyclonal
antibody specifically recognizing cFos (1:7,500 in incubation solution; 17 hours; SC-52;
Santa Cruz Biotechnology, Santa Cruz, CA, USA) followed by incubation with a
biotinylated donkey anti-rabbit IgG (1:500 in incubation solution; 1 hour; Jackson
Immunoresearch Laboratories, West Grove, PA, USA) and avidin-horseradish peroxidase
complex (1:1,000 in PBS; 1 hour; ABC Elite Kit, Vector Laboratories, Burlingame, CA,
USA). Reaction product was visualized using diaminobenzidene (DAB; Sigma-Aldrich,
St. Louis, MO, USA) solution (0.01% DAB, 0.012%, H202in 0.1M PB) containing 0.08%
nickel sulphate for 10 minutes, resulting in a black reaction product. Sections were then
washed with H202 (1% in PBS; 10 minutes) and incubated with a mouse monoclonal
antibody to tyrosine hydroxylase (TH; 1:400,000 in incubation solution; 17 hours;
Chemicon International, Temecula, CA), a biotinylated donkey anti-mouse IgG (1:500 in
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PBS; 1 hour; Jackson Immunoresearch Laboratories, West Grove, PA, USA) and ABC
(1:1,000 in PBS; 1 hour). TH-immunoreactivity was visualized with DAB (0.01% DAB,
0.012%, H202 in sodium phosphate buffer [PB; 0.1 M]; 10 minutes), resulting in brown
reaction product. Finally, sections were thoroughly rinsed in PB, mounted on pluscharged slides (Fisher Scientific, Ottawa, Canada) dehydrated in alcohol, cleared with
Citrisolv (Fisher Scientific, Ottawa, Canada), and coverslipped with Di-N-Butyl
Phthalate in xylene (Electron Microscopy Sciences, Fort Washington, PA).

Cell Counting and Analysis
cFos immunoreactive (IR) neurons were counted in reward-related brain areas
using a Leica DMR microscope (Leica Microsystems,Wetzlar, Germany) with a camera
lucida drawing tube by an observer blinded to the experimental groups, in standard areas
of analysis (Fig. 3.1): nucleus accumbens (NAc) core (400x600 μm) and shell
(400x600μm) ; the anterior cingulate area (ACA; 400x600 μm), the infralimbic (IL;
400x600μm) and the paralimbic (PL; 400x600 μm) regions of the medial prefrontal
cortex (mPFC); central (CeA; 400x400 μm) and basolateral (BLA; 600x400 μm)
amygdala; and dentate gyrus (DG; 1800x1200 μm). In the VTA (900x600 μm), cFos-ir,
TH-ir, and dual labeled neurons were counted at a rostral-middle level (Balfour, et al.,
2004). More caudal levels of VTA were not included as no cFos expression was noted at
any time points. Counts of cFos-IR cells in the suprachiasmatic nucleus of the
hypothalamus (SCN, 400x400 μm) were performed as a positive control of circadian
activation rhythms (Schwartz et al., 2000). Areas of analysis were determined in
accordance with previously defined landmarks(Swanson, 1998, Fig. 3.1). For each
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animal, an average of two counts (each in one hemisphere) was calculated. One way
ANOVA and Kruskal-Wallis analyses were performed, to determine the effect of timeof-day on cFos in each brain area. In the VTA, Kruskal-Wallis analyses were performed
to identify effects of time on c-Fos, TH, and dual cFos/TH. Dunn’s post-hoc analyses
were used where needed to determine the timepoints with highest (peaks) and lowest
(nadirs) immunoreactivity. In the SCN, unpaired t-test was used to determine significant
difference in cFos-ir between ZT6 and 18.

67

68

Figure 3.1: Standard areas of analyses for cell counts. Schematic representations of
areas of analyses in A) anterior cingulate area (ACA), infralimbic (IL), and prelimbic
(PL) regions of medial prefrontal cortex; B) nucleus accumbens (NAc) core and shell; C)
central (CeA) and basolateral (BLA) amygdala; D) dentate gyrus (DG); E)
suprachiasmatic nucleus (SCN); F) ventral tegmental area (VTA) (F). Abbreviations: ac,
anterior commissure; aq, cerebral aqueduct; cc, corpus callosum; cp, caudate putamen; fr,
fasciculus retroflexus; fx, fornix; ml, medial lemniscus; ot, optic tract; 3V, third ventricle;
st, stria terminalis; lv, lateral ventricle. Drawings modified from Swanson (1998).
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3.2.3 mPFC lesions
Lesion Surgery
Lesion surgeries were performed using parameters we previously reported to
result in lesions restricted to IL and PL (Davis et al., 2010). Rats were anaesthetized with
ketamine (87 mg/ml/kg i.p.) and xylazine (13 mg/ml/kg i.p.) and placed in a stereotaxic
apparatus (Kopf Instruments, Tujunga, California). The skull was exposed and a small
burr hole was drilled and a 5µL Hamilton Syringe (Hamilton, Reno, Nevada) was
lowered at the following coordinates relative to bregma: anterior-posterior = 2.9, mediallateral = 0.6 mm. Ibotenic acid (2% in 0.1 M phosphate buffered saline; Sigma) or
vehicle was slowly infused bilaterally at two dorsal-ventral coordinates corresponding to
the infralimbic and prelimbic regions of the mPFC (from the top of skull = 5.0 and 2.5
mm; 0.25 µL/1-minute per injection). The needle was left in place for 3 minutes
following each injection to allow for optimal diffusion. Animals were allowed two
weeks to recover from surgery prior to tissue collection.

cFos Immunocytochemistry
Sham- and mPFC-lesioned rats were perfused at two different time points, ZT10
and ZT18, corresponding respectively to nadirs and peaks in cFos-IR (n=6-8 per timepoint). Brain sections containing the NAc core and shell, and rostral and middle VTA
were processed and analyzed for cFos immunocytochemistry, as described above. Twoway ANOVA was used to analyze effects of lesion (lesion versus sham) and time-of-day
(ZT10-ZT18). Fisher LSD tests were used for post-hoc analysis of time-of-day
differences and lesion effects.

70

Lesion Verification
The locations of ibotenic lesions in the mPFC were assessed in cFos
immunostained tissue. Rats with >80% tissue loss of PL and IL were considered lesioned
(Davis, et al., 2010), and had minimal or no damage to the anterior cingulated area or
nucleus accumbens (ZT10; n=6; ZT18; n=8). Sham animals did not have any damage
(ZT10; N=6; ZT18; n=4).

3.3 RESULTS
3.3.1 Rhythmic baseline neural activation in the reward system
A significant diurnal variation in the number of cFos-IR cells was observed (Fig.
3.2) in the NAc core (K=22.99, p=0.0003, Fig. 3.3a) and shell (K=27.57, p<0.00001, Fig.
3.3b), in all three subregions of the mPFC (ACA [K=20.73, p=0.0009, Fig. 3.4a], PL
[K=18.78, p =0.0021, Fig. 3.4B], and IL [K=13.70, p=0.0177], Fig. 3.4C), and in the
VTA (K=23.99, p=0.0002, Fig. 3.5A].

In general, rhythms in NAc, mPFC, and VTA were similar in phase. In the NAc
core and shell, cFos expression had a nadir at ZT10 and a peak from ZT18 to ZT22 (Fig.
3.2-3.3). Within the subregions of the mPFC, cFos was at a nadir at ZT10 and at a peak
at ZT18 (IL, PL) or from ZT14-ZT18 (ACA; Fig. 3.2, 3.4).

In the VTA, cFos nadir was at ZT10 and peak from ZT18 to ZT22 (Fig. 3.2, 3.5).
The number of TH cells co-expressing cFos immunoreactivity also varied diurnally (F=
34.27, p<0.0001, Fig. 3.5C) with a nadir at ZT10 and peak at ZT18. Moreover, at peak
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times, 24% of total VTA TH-IR cells also expressed cFos, and 20% of cFos-ir cells
expressed TH (Fig. 3.5D). Finally, a rhythm in the number of TH expressing cells was
observed with a nadir at ZT10 and peaks at ZT06, 14, and 22 (Fig. 3.5B).

In contrast, no diurnal variations in numbers of cFos-IR cells were observed in the
dentate gyrus or the central and basolateral amygdala (Fig. 3.6A,B,C). In the SCN, the
number of cFos-IR cells was significantly greater at ZT06 then ZT18 (p=0.0022, fig.
3.6D) consistent with previous reports (Schwartz, et al., 2000).
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Figure 3.2: cFOS and TH immunoreactivity. Images showing Fos-ir (black) and TH-ir
(brown) in mPFC (prelimbic area), NAc (core and shell), and VTA in representative
animals at ZT10 (A, C, E) and ZT18 (B, D, F). Arrows in F indicate cells co-expressing
Fos and TH-ir. Scale bar depicts 100 (A-D) or 50 (E,F) μm. cc= corpus callosum
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Figure 3.3: Diurnal variation in neural activation in the nucleus accumbens (NAc).
Number of cFos-IR cells in the NAc shell (A) and core (B). Data are expressed as
means ± SEM. Different letters denote significant differences between time points.
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Figure 3.4: Diurnal variation in neural activation in the prefrontal cortex. Number
of cFos-IR anterior cingulate area (ACA; A), infralimbic region (IL; B), and prelimbic
region (PL; C) of the medial prefrontal cortex. Data are expressed as means ± SEM.
Different letters denote significant differences between time points.
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Figure 3.5: Diurnal variation in activation of dopaminergic and non-dopaminergic
neurons in the ventral tegmental area. Diurnal variation in number of cFos, TH, dual
cFos/TH immunoreactive cells, and percentage of TH cells co-expressing cFos in the
ventral tegmental area. Data are expressed as mean number ± SEM. Different letters
denote significant differences between time points.
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Figure 3.6: Diurnal variation in neural activation in the amygdala, hippocampus
and suprachiasmatic nucleus. Diurnal variation in number of cFos immunoreactive
cells in the basolateral amygdala (BLA; A), the central amygdala (CeA; B), dendate
gyrus (C), and suprachiasmatic nucleus (SCN; D). Data are expressed as mean ± SEM. *
denotes significant differences between time points.
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3.3.2 mPFC lesions attenuate cFOS-IR in NAc
mPFC lesions had a significant effect on cFos rhythms in NAc shell (Fig. 3.7A)
and core, Fig. 3.7B), but not in the VTA (Fig. 3.7C). In the NAc, mPFC lesions had a
significant effect on numbers of cFos-IR cells in both the core (F=22.5, p=0.0002) and
shell (F=22.57, p=0.0001). Moreover, significant interactions were found between timeof-day and lesion status for the NAc shell (F=50.0, p<0.0001) and core (F=32.94,
p<0.0001). Post-hoc analysis revealed that mPFC lesions reduced the number cFos-IR
cells at ZT18 (core: p=0.0003; shell: p=<0.0001), compared to sham group, and increased
cFos-ir at ZT10, in the shell (p=0.019), but not the core. Changes in numbers of cFos-IR
cells with mPFC lesions resulted in a loss of time-of-day differences in the NAc shell,
and an attenuation of the difference in the NAc core (ZT10 versus 18: p=0.0258). In
contrast to the NAc, mPFC lesions did not affect the number of cFos-IR cells in the VTA
and a significant time-of-day difference was observed in lesioned animals (ZT10 versus
18: p<0.0001). Finally, sham treatment did not disrupt diurnal rhythms in cFos-ir and
significant time-of-day differences were detected in NAc core (p<0.0001), NAc shell
(p<0.0001), and VTA (p=0.0161), consistent with the findings described above. These
results suggest that mPFC inputs may mediate neural activity rhythms in NAc, but not in
VTA.
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Figure 3.7: The prefrontal cortex modulates neural activity in the mesolimbic
reward system. Effects of sham surgery and mPFC lesions on cFos immunoreactivity in
the nucleus accumbens (NAc) core (A) and shell (B), and ventral tegmental area (VTA;
C). Data are expressed as mean ± SEM. * denotes significant effect of time-of-day
within treatment group, and # denotes significant lesion effect within time of day.
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Figure 3.8: cFos immunoreactivity in prefrontal-cortex-lesioned brains. Images
showing mPFC in representative Sham (A) and Lesion (B) animals, in brain sections
immunoprocessed for cFos immunoreactivity. Arrows in B indicate the extent of the
lesion site encompassing prelimbic (PL) and infralimbic (IL) areas, with sparing of the
anterior cingulate area (ACA). Images in C and D illustrate cFos-IR in NAc shell at ZT18
in sham (C) and mPFC-lesioned (D) males. Scale bars indicate 250 (A, B) or 100 (C, D)
μm. Abbreviations: cc, corpus callosum.
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3.4 DISCUSSION
The current study demonstrated temporal patterns of neural activation in the VTA,
NAc, and mPFC, which were generally elevated during the dark phase (ZT18-ZT22),
with nadirs during the end of the light phase (ZT10). In the VTA, this rhythm in neural
activation was observed in dopaminergic as well as non-dopaminergic cells. One major
question deriving from these observations was: what is driving these rhythms in neural
activation? Since both NAc and VTA receive glutamatergic inputs from mPFC (Carr &
Sesack, 2000; Gabbott, Warner, Jays, Salway, & Busby, 2005; Sesack & Grace, 2010),
we tested the hypothesis that mPFC glutamatergic inputs contribute to the neural activity
rhythms. Indeed, ablation of the mPFC eliminated diurnal variation in NAc cFos-IR by
eliminating the peak expression at ZT18, but did not affect rhythms in VTA activity.

This study conducted a comprehensive characterization of diurnal rhythms in
cFos-IR in the mesocorticolimbic reward system. Diurnal rhythms with peaks during the
middle-end of the dark phase and nadirs during the end of the light phase were
demonstrated in the NAc, VTA, and mPFC, but not in the CeA, BLA, or DG. There have
been previous papers using cFos as a marker for daily changes in neural activity,
however, these included only a few time points or were limited to a particular portion of
the day. Overall, the phases of these rhythms were consistent with our own observations.
Specifically, a qualitative investigation of cFos protein expression during sleep and wake
states reported peak cFos-IR at ZT18 (dark phase) compared to ZT6-9 (light phase) in
the mPFC and NAc (Pompeiano et al., 1994). Additionally, data from studies of food
anticipatory behaviour also reported variations in cFos-IR in the NAc, mPFC and CeA,

83

over a period of several hours (Angeles-Castellanos, Mendoza, & Escobar, 2007;
Verwey, Khoja, Stewart, & Amir, 2007). The absence of rhythms in neural activation in
the hippocampus and amygdala under basal conditions suggests that these regions may
not be involved in mediating rhythms in reward. However, there is evidence to support
their role as accessory regions, sensitive to the timing of rewards in the environment.
Salient stimuli such as palatable food and restricted feeding schedules alter patterns of
neural activation and clock gene expression throughout the reward system (Mendoza,
Angeles-Castellanos, & Escobar, 2005) and can generate rhythmicity in the DG and
amygdala (Verwey, et al., 2007). As these regions project to the mPFC, NAc and VTA
(Kelley, 2004), under these conditions, they may convey timing information throughout
the reward system and to other brain areas.

The mPFC, NAc and VTA are tightly interconnected, and form a major
component of the neural circuits involved with motivation and reward (Hyman, Malenka,
& Nestler, 2006; Kelley & Berridge, 2002)). The finding that rhythms in neural activity
are similar within this network forms the basis for several hypotheses regarding the
generation of these activity rhythms. First, it is possible that glutamatergic and
dopaminergic inter-connections originating from the mPFC and VTA (Carr & Sesack,
2000; Sesack, Carr, Omelchenko, & Pinto, 2003) modulate the activity within this
network. Indeed, one main finding of the current study is that mPFC inputs are critical
for the diurnal rhythms in activity in the NAc, suggesting that these rhythms are
influenced by glutamatergic mPFC outputs. These findings are consistent with previous
reports of circadian rhythms in glutamate in NAc dialysate (Castaneda, de Prado, Prieto,
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& Mora, 2004; Marquez de Prado et al., 2000), with peaks around ZT18 and remains low
throughout the middle light phase.
Conversely, VTA rhythms were not dependent on mPFC inputs. Therefore, a
second hypothesis is that rhythms in activation of VTA, mPFC, and potentially NAc
neurons, instead derive via inputs from other brain areas, including via the master
circadian clock, the SCN, in the hypothalamus. The VTA is positioned to receive timing
information from the SCN via two indirect circuits; one through the medial preoptic
nucleus (Luo & Aston-Jones, 2009), the other by way of orexinergic neurons in the
hypothalamus, (Deurveilher & Semba, 2005; Korotkova, Sergeeva, Eriksson, Haas, &
Brown, 2003; Yoshida, McCormack, Espana, Crocker, & Scammell, 2006). There is
currently little evidence to support a functional role of the former pathway, while the
latter, orexinergic pathways appears ideally positioned to convey circadian information to
the reward system. A large number of orexinergic efferents contact the VTA (Fadel &
Deutch, 2002), and in addition to its familiar role in arousal and wakefulness (Sakurai,
2007), the orexin system has been implicated in the regulation of reward and addiction
(Aston-Jones, Smith, Moorman, & Richardson, 2009; Harris, Wimmer, & Aston-Jones,
2005) via its role in mediating reward induced activation of VTA dopamine neurons
(Borgland, Taha, Sarti, Fields, & Bonci, 2006; Zheng, Patterson, & Berthoud, 2007). The
influence of orexinergic inputs to VTA dopamine activity fluctuates over the course of
the day, with greater activation during the dark phase (Moorman & Aston-Jones, 2010).
Moreover, orexin neurons receive direct inputs from the SCN (Cutler et al., 1999;
McGranaghan & Piggins, 2001). Perturbations in SCN activity with phase shifting or
SCN ablation alters (Akiyama et al., 2004; Marston et al., 2008; Zhang et al., 2004) the
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normal diurnal rhythms of orexin activation and signalling (Estabrooke, et al., 2001; Lee,
Hassani, & Jones, 2005). Interestingly, clock gene expression in forebrain regions is
attenuated in mice lacking orexin neurons (Akiyama, et al., 2004). Together these
findings suggest an integrated functional relationship between the circadian, orexigenic,
and reward systems.

Moorman and Aston-Jones (2010) recently showed that the activity of VTA DA
neurons during the dark phase is modulated by the mPFC and orexinergic afferents, with
a gating role of orexin on enhancing mPFC excitatory control over DA neurons.
Glutamatergic projections from the mPFC reach both dopaminergic and nondopaminergic neurons of the VTA (Omelchenko & Sesack, 2007; Rossetti, et al., 1998).
Modulation of corticolimbic glutamatergic inputs by orexin has been suggested to occur
via increased NMDA receptor trafficking (Borgland, et al., 2006) and via orexin receptor
mediated changes in phosphoinositol signalling (Moorman & Aston-Jones, 2010). In the
current study, we did not observe an effect of mPFC lesions on peak expression of VTA
neural activity, suggesting that mPFC inputs did not have a major contribution to baseline
excitation. However, it is possible that orexin inputs in mPFC lesioned animals are
sufficient to maintain the VTA activity rhythms.

We hypothesized that the observed rhythms in neural activation in the NAc and
mPFC were in part mediated by dopamine originating from the VTA. Indeed, a diurnal
pattern of activated dopaminergic cells was evident in the VTA, consistent with the
neural activity rhythms observed in the NAc and mPFC. Dopaminergic afferents to the
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mPFC primarily originate from the VTA (Kelley & Berridge, 2002; Sesack & Grace,
2010), and may be responsible for conveying timing information to the mPFC, and thus
indirectly to the NAc. A significant time-of-day effect has been previously reported in
mPFC dopamine clearance in mPFC, a measure of synaptic dopamine (Sleipness, Jansen,
Schenk, & Sorg, 2008). The rhythm in PFC dopamine clearance is consistent with the
pattern in VTA dopaminergic activity (Webb, Baltazar, Wang, et al., 2009), with peak at
ZT04, and nadir at ZT0. However, the dopamine clearance rhythm does not match the
rhythm in cFos activity; hence may not be causing the rhythms in neural activity. In
addition, a subportion of the rhythmic cFos-IR in the VTA neurons may be
glutamatergic. Luo et al. (2008) reported that VTA neurons that fire selectively during
the active night-phase express mRNA for the glutamate cell marker, vGLUT2, and
account for 14% of all active cells during the dark phase. Moreover, a subset of
dopaminergic neurons also synthesize and release glutamate into the NAc (Tecuapetla et
al., 2010). These findings suggest that VTA neural activation may contribute to rhythms
in NAc and mPFC, via release of glutamate and/or dopamine.

A final hypothesis for generating neural activity rhythms in the mPFC, VTA, and
NAc, is that these originate from oscillation in core clock genes. Core clock genes have
been localized to many reward-related brain areas (Angeles-Castellanos, et al., 2007;
McClung et al., 2005; Ramanathan, Stowie, Smale, & Nunez, 2010; Verwey, et al., 2007;
Webb, Baltazar, Wang, et al., 2009), and oscillate in the NAc and PFC (AngelesCastellanos, et al., 2007) but do not appear to be rhythmically expressed in the VTA
(Webb, Baltazar, Wang, et al., 2009). It is clear that core clock genes play a role in
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regulating reward as clock gene disruptions alter typical behavioural responses to drugs
of abuse. For instance, per1 and per2 knockout mice display increased and decreased
cocaine conditioned place preference, respectively (Abarca, et al., 2002);
intracerebroventricular injections of a DNAzyme that interferes with per1 impairs
morphine CPP (Liu et al., 2005); arrhythmic per2 mutant mice exhibit increased alcohol
consumption; and mice lacking a functional Clock gene are hypersensitive to cocaine
(McClung, et al., 2005). Clock genes disruptions also affect the normal functioning of
the reward system. For instance, Clock gene knockout mice have increased excitability
of dopamine neuron and increased TH expression in the VTA (McClung, et al., 2005);
per2 knockout mice exhibit altered dopamine activity, with decreased transcription of the
monoamine oxidase gene throughout the mesolimbic dopamine system, and increased
extracellular levels of dopamine and altered neural activity in the striatum (Hampp, et al.,
2008); VTA specific knockdown of clock genes in mice results in increased dopamine
cell firing and altered expression of genes associated with reward, such as increased TH,
dopamine receptor, and Homer2, and decreased ionotropic glutamate receptor subunit 2,
and dopamine beta-hydroxylase (Mukherjee et al., 2010).

In summary, the current study demonstrates diurnal rhythms in neural activity in
areas within the mesolimbic pathway with a causal role for mPFC outputs to generate
such rhythms in the NAc. These neural activity rhythms in turn may regulate diurnal
differences in reward behaviours. The nadir cFos-IR during the late light phase coincides
with a nadir in expression of psychostimulant reward (Baird & Gauvin, 2000; Roberts &
Andrews, 1997; Roberts, Brebner, Vincler, & Lynch, 2002; Webb, Baltazar, Wang, et al.,
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2009). In contrast, the peak in cFos expression correlates with high expression of reward
for the natural reward behaviour mating and for amphetamine (Webb, Baltazar, Wang, et
al., 2009). Future studies will be needed to test if these activity rhythms and rhythms in
dopamine and glutamate signaling are indeed critical for rhythms in reward behaviour.
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CHAPTER 4:
Medial Prefrontal Cortex Modulates Diurnal Rhythms
in Amphetamine Reward
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4.1 INTRODUCTION

Behavioural responses to drugs of abuse vary by time-of-day. This includes
diurnal variations in self-administration, behavioural sensitization, and conditioned place
preference (CPP) for psychomotor stimulants (Abarca, Albrecht, & Spanagel, 2002;
Baird & Gauvin, 2000; Webb et al., 2009). The timing of peak reward for these
substances is typically in the early light phase of the light/dark cycle, coinciding with the
normal inactive period for rodents. The rewarding effects of drugs of abuse are mediated
by the mesolimbic reward system, of which dopamine is one of the key neurotransmitters
(Ikemoto, 2007; Spanagel & Weiss, 1999). Dopamine cell bodies are located in the
ventral tegmental area (VTA) and project to other structures involved in the processing of
rewards, including the medial prefrontal cortex (mPFC), the nucleus accumbens (NAc),
the amygdala, and the hippocampus (Kelley & Berridge, 2002). Daily changes in reward
likely reflect oscillations in mesolimbic activity. Indeed, time-of-day differences have
been reported for several markers of dopamine synthesis, release, and metabolism,
throughout the mesolimbic system (Castaneda, de Prado, Prieto, & Mora, 2004; Sleipness,
Jansen, Schenk, & Sorg, 2008; Sleipness, Sorg, & Jansen, 2007; Webb, et al., 2009).
There are also reports of diurnal rhythms in the extracellular concentration of other
reward-related neurotransmitters, including glutamate and gamma-aminobutyric acid
(GABA) (Castaneda, et al., 2004), as well as in neural activity (Luo, Georges, & AstonJones, 2008) and neural activation in this system (see chapter 3). The nature of the
timing signal that drives the observed rhythms in reward and mesolimbic activity has yet
to be determined.
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Clock genes drive rhythms in circadian oscillators, including the master circadian
oscillator in the suprachiasmatic nucleus (SCN) (Albrecht, 2012; Dibner, Schibler, &
Albrecht, 2010), and have been reported to be rhythmically expressed in reward-related
brain areas (Angeles-Castellanos, Mendoza, & Escobar, 2007; Li, Liu, Jiang, & Lu,
2009). However, in the VTA, clock genes appear to be insufficient to drive rhythms in
dopamine activity (Webb, et al., 2009), neural activation (see chapter 3) and neural
activity (Luo, et al., 2008), which occur despite a lack of intrinsic clock gene oscillations
(Abe et al., 2002; Webb, et al., 2009). Thus, rhythms in reward may also be driven by a
timing signal originating elsewhere. The SCN master clock is responsible for entraining
rhythms in extra-SCN oscillators (Yamazaki et al., 2000), and two putative signal
pathways between the SCN and the VTA have been identified (Deurveilher & Semba,
2005; Korotkova, Sergeeva, Eriksson, Haas, & Brown, 2003; Luo & Aston-Jones, 2009) .
However, rhythms in reward have been shown to persist in the absence of an SCN signal
(Iijima, Nikaido, Akiyama, Moriya, & Shibata, 2002; Sleipness, et al., 2007), suggesting
that a timing signal originates from within the mesolimbic system.

The purpose of this study is to demonstrate the role of the mPFC in mediating
the diurnal differences in behavioural measures of amphetamine reward. The mPFC is
important for the execution of reward behaviour, with a role in reward-based learning,
motivation, decision-making, and response inhibition (Hyman, Malenka, & Nestler, 2006;
Miller & Cohen, 2001; Ridderinkhof, van den Wildenberg, Segalowitz, & Carter, 2004;
Rolls, 2004). Moreover, the mPFC exhibits diurnal rhythms in dopamine, glutamate,
GABA activity (Castaneda, et al., 2004), neural activation (see chapter 3), and clock gene
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expression (Angeles-Castellanos, et al., 2007; Li, et al., 2009), which in turn may drive
rhythms in other mesolimbic areas. Glutamatergic efferents of the mPFC innervate many
of the reward related brain areas that exhibit diurnal oscillations in protein and gene
expression, including the NAc and VTA (Gabbott, Warner, Jays, Salway, & Busby,
2005). Neurotoxic ablation of the mPFC dampens neural activation in the NAc,
eliminating time-of-day differences (see Chapter 3). These observations led us to
hypothesize that the mPFC is orchestrating the timing of reward rhythms. To test this
hypothesis, we lesioned the mPFC and determined the resulting changes to the daily
rhythm in amphetamine reward, using a CPP paradigm. Similarly, we pharmacologically
inactivated the mPFC with GABA agonists during CPP conditioning or post-test to
determine if mPFC modulation of reward rhythms was occurring during the acquisition
or expression of CPP.

4.2 METHODS
4.2.1 Animals
Adult male Sprague-Dawley rats (300-350g, Charles River Laboratories, QC,
CAN) were single housed in standard rat housing cages under a 12:12 light/dark cycle
(~350lux L/0 lux D) with ad libitum food and water. Following arrival, animals were
allowed to acclimatize for 1 week prior to surgery and 2 weeks for recovery and light
cycle entrainment. All experiments were approved by the University of Western Ontario
Animal Care Committee and the University Committee on Use and Care of Animals at
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the University of Michigan and are in compliance with the guidelines of the Canadian
Council on Animal Care and the U.S. National Institute of Health.

4.2.2 Prefrontal cortex lesion surgery
Rats were anaesthetized with ketamine (87 mg/ml/kg i.p. ) and xylazine (13
mg/ml/kg i.p.) and placed in a stereotaxic apparatus (Kopf Instruments, Tujunga,
California) with the skull leveled horizontally relative to bregma and lamda. Skull was
exposed and a small burrhole was drilled above the injection site at the following
coordinates relative to bregma: anterior-posterior = 2.9, medial-lateral = 0.6 mm.
Ibotenic acid (2% in phosphate buffered saline) or vehicle was slowly infused bilaterally
at two dorsal-ventral coordinates corresponding to the infralimbic and prelimbic regions
of the mPFC (from the top of skull=: 5.0 and 2.5 mm; 0.25 µL/1-minute per injection)
using a 5µL Hamilton Syringe (Hamilton Reno Nevada). Rats were given two weeks for
post-operative recovery before any behavioral testing.

4.2.3 Prefrontal cortex cannulae placement surgery:
Rats were anaesthetized and placed into stereotaxic apparatus as above. Two
small burrholes were drilled at anterior-posterior = 3.0 mm, and medial-lateral = ±1.7
mm . Stainless steel cannulae (5mm, 22 gauge, Plastics One) were implanted bilaterally
using a cannula insertion tool mounted to the stereotaxic frame and lowered at a 15
degree angle to a depth of -3.7 mm from the skull to target the IL/PL junction. The
cannulae were fixed in place using layered dental acrylic and small screws affixed to the
skull at three locations. Dummy cannulae (5mm, Plastics one) were screwed into the
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guide cannulae to maintain tract cleanliness and keep out foreign objects. Rats were given
two weeks for post-operative recovery before any behavioral testing.

4.2.4 Amphetamine conditioned place preference
Sham-, mPFC-lesioned, and cannulated rats received a week of habituating
subcutaneous injections of saline immediately prior to behavioural testing for
amphetamine-induced conditioned place preference (CPP) as described in Webb et al.,
2009. Cannulated rats received additional handling for 1 week prior to CPP to habituate
them to conditions of the drug microinfusion and to check guide cannula blockages.
Each animal was conditioned and tested at either ZT11 or ZT23, consistent with the
previously observed nadirs and peaks in amphetamine CPP, respectively (Webb, et al.,
2009). During a pretest, animals freely roamed the CPP apparatus (Med Associates, St.
Albans, Vermont) for 15 minutes to determine the time each animal spent more in
chamber than the other. As a group, animals do not show a preference for either chamber,
and rats with an initial protracted preference for a given chamber (>120 seconds), were
excluded from the study ( <15% of subjects). Rats underwent conditioning on days 2 and
3; the initially un-preferred chamber was paired for 30 minutes with amphetamine (2.5
mg/kg, subcutaneous at 1ml/kg, D-amphetamine sulfate in sterile 0.9% saline, calculated
based on the free base), while the preferred chamber was paired for 30 minutes with
vehicle (0.9% saline, subcutaneous at 1 ml/kg) on alternate days in a counterbalanced
manner. Next, a post-conditioning preference test (post test), identical to pretest was
conducted to determine reward-induced changes in chamber preference. CPP scores, the
change in time spent in the amphetamine-paired-chamber before and after conditioning,
were calculated and analyzed for lesion- and time-of-day effects via two-way ANOVA
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with bonferonni post-hoc analysis. Difference scores (the difference in time spent in the
paired versus unpaired chamber) were also calculated for all groups and analyzed for preand post-conditioning effects by paired T-Test.

4.2.5 Intracranial drug infusions

A drug cocktail was prepared consisting of 1ug/ul of GABAA agonist muscimol
(Sigma) and 0.2 ug/ul of GABAB agonist baclofen (Sigma) dissolved in sterile saline.
Prior to microinfusion, dummy caps were removed and a 6mm 28 gauge injector cannula
was lowered into each implanted guide cannula and screwed in place. 0.5 μl of drug or
saline was infused into each hemisphere, simultaneously, at 0.25μl/min. Microinfusions
were made by means of a microinjector pump (Harvard Apparatus) and 10 μl glass
syringes (Hamilton) connected to the injector cannulae via plastic tubing (Plastic One).
Following drug infusion, injector cannulae were left in place for an additional minute to
maximize diffusion of drug. Rats were returned to home cage for 10 minutes prior to CPP.
Rats were either infused with inhibitor cocktail (drug) or vehicle on both conditioning
days to test effects during the acquisition phase of CPP, or during the post-test day only
to test effects on the expression of CPP. Moreover, infusions and CPP testing occurred
either at ZT11 or at ZT23.

4.2.6 Verification of lesion and cannula placement
Following post-test, cannulated, sham- and mPFC-lesioned rats, were deeply
anaesthetized with sodium pentobarbital (270 mg/kg, i.p.), decapitated, brains were
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rapidly removed, frozen on dry ice, and stored at -80°C, sectioned coronally (35 µm)
using a cryostat (Leica Microsystems,Wetzlar), mounted directly onto plus-charged slides
(Fisher Scientific, Ottawa, Canada) in series and post fixed in paraformaldehyde (4% in
0.1M PB) for one hour. Mounted sections containing the mPFC were stained for nissl
(.625% Cresyl Violet Acetate (Sigma-Aldrich, St. Louis, MO, USA) in .0625% sodium
acetate trihydrate (Fisher Scientific, Ottawa, Canada) in ddH20, pH 3.14), dehydrated in
alcohol, cleared with Citrisolv (Fisher Scientific, Ottawa, Canada), and coverslipped with
Di-N-Butyl Phthalate in xylene (Electron Microscopy Sciences, Fort Washington, PA).

The extent and locations of the lesions were assessed as previously described
(Davis et al., 2010), Animals with >80% loss of PL and IL were considered lesioned
animals; 18 sham-operated, 19 lesioned. Lesioned animals had minimal or no damage to
the anterior cingulated area or nucleus accumbens. Moreover, sham animals did not have
any cell loss in mPFC or neighbouring brain regions. Successful cannula placements
were those where tracts terminated at the IL/PL interface, in accordance with known
landmarks (Swanson, 1998); for acquisition phase injections, n=13 vehicle, 24 drug; for
expression phase, 17 vehicle, 20 drug.
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Figure 4.1: cresyl violet stain in lesioned and sham-operated prefrontal cortex.
Images show mPFC in representative sham-operated (left panel) and lesion (right panel),
in brain sections stained with Cresyl Violet. Arrows on indicate extent of the lesion site;
on the right, encompassing the infralimbic (IL) and prelimbic (PL) areas, with sparing of
the anterior cingulate cortex area (ACA); on the left, sparing the IL, PL, and ACA. Scale
bars indicate 250 μm. Abbreviations: cc, corpus callosum.
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4.3 RESULTS
4.3.1 mPFC lesion CPP
mPFC lesions had a significant effect on diurnal rhythms in amphetamine-induced
CPP. Sham animals had a significantly higher CPP score at ZT 23 compared to ZT11
(t=2.365, p<0.05), consistent with our previous findings (Webb et al, 2009). There was a
significant effect of lesion on CPP score (F(1,33) =7.038, p<0.05, Figure 4.1), such that
lesioned males had a significant increase in CPP score at ZT11 (t=2.8, p<0.05) compared
to sham animals. There were no differences between sham and lesioned males at ZT23.
Due to the increase in CPP score at ZT11 in lesioned rats, there was no significant
difference in CPP score between ZT11 and ZT23. Similar effects were observed for
difference scores. At ZT11, lesioned, but not sham males, had a significant increase in
time spent in the amph-paired chamber (t=3.525, p<0.05). At ZT23, both mPFC lesion
(t=4.658, p<0.05) and sham (t=2.372, p<0.05) males formed a significant CPP. Thus,
amphetamine-induced CPP was formed at ZT11 in the lesion group but not the shamoperated group, and in both groups at ZT23.
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Figure 4.2 The mPFC modulates diurnal rhythms in amphetamine-induced
conditioned place preference. Time-of-day differences in amphetamine-induced
conditioned place preference in mPFC lesioned (lesion) and sham-operated (sham) rats.
Data expressed as mean ± SEM in (A) CPP score: the change in time spent in
amphetamine paired-chamber after before and after conditioning; and (B) difference
score: the difference in time between paired and un-paired chamber. * denotes significant
differences in CPP score between ZT11(11) and ZT23(23), or in difference score
between post (post) and pre (pre) test days of the CPP procedure; # denotes significant
differences in CPP score between sham and lesion at ZT11 .
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4.3.2 mPFC GABA agonist infusions
Overall, infusion of GABA agonists into the mPFC prior to acquisition or
expression of amphetamine CPP mimicked the effects caused by lesions and resulted in
an increased CPP at ZT11 and a subsequent loss of time-of-day differences. For infusions
during the acquisition phase, there was a significant effect of the drug on CPP score
(F(1,33)= 4.393, p<0.05) that was dependent on the time-of-day (F(1,33)=7.191, p<0.05,
interaction effect), while no overall time-of-day effect was observed. In vehicle infused
rats, there was a significant difference in CPP score between ZT11 and ZT23 (t=2.688,
p<0.05) that was not observed with drug infusions. The loss of the time-of-day difference
in the drug infused group was mediated by an increase in CPP score at ZT11 in the drug
infused groups (t=3.344, p<0.05) compared to the vehicle group. CPP score at ZT23 was
not affected by drug infusions and there were no differences between vehicle and drug
groups. Similar effects were observed with difference scores. Significant pre- and posttest differences were observed at ZT11 (t=2.956, p<0.05) following drug infusion but not
with saline infusions. At ZT23, significant pre- and post-test differences were observed
irrespective of drug (t=1.195, p<0.05) or saline (2.067) infusion. Thus, amphetamineinduced CPP was formed at ZT11 in the drug infused group but not the vehicle group,
while CPP at ZT23 was not affected and formed in both groups.

107

108

Figure 4.3: mPFC inactivation during acquisition phase prevents time-of-day
differences in amphetamine-induced conditioned place preferences. Time-of-day
differences in amphetamine-induced conditioned place preference in rats receiving mPFC
infusions of GABA agonist cocktail (DRUG) or vehicle during conditioning. Data
expressed as mean ± SEM in (A) CPP score: the change in time spent in amphetamine
paired-chamber after before and after conditioning; and (B) difference score: the
difference in time between paired and un-paired chamber. * denotes significant
differences in CPP score between ZT11(11) and ZT23(23), or in difference score
between post-test (post) and pre-test (pre); # denotes significant differences in CPP score
between sham and lesion at ZT11.
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For infusions during the expression phase, there were unexpected effects of
infusions of either vehicle or drug. The time that animals spent in the middle chamber
across all groups was increased irrespective of drug treatment or time-of-day. As a result,
the CPP score was not calculated as it is affected by middle chamber time. However,
effects of drug infusions on the difference scores were consistent with those observed for
acquisition phase infusions. Significant increases in time spent in the amphetaminepaired chamber were observed in drug, but not vehicle-infused males at ZT11 (t=3.227,
p<0.05). At ZT23, there were no effects of drug, and both drug (t=3.093, p<0.05) or
vehicle (t=5.988, p<0.05)-treated males formed a significant CPP. Again, amphetamineinduced CPP was formed at ZT11 in the drug infused group but not the vehicle group,
and mPFC inhibition did not affect CPP at ZT23.
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Figure 4.4: mPFC inactivation during expression phase prevents time-of-day
differences in amphetamine-induced conditioned place preferences. Time-of-day
differences in amphetamine-induced conditioned place preference in rats receiving mPFC
infusions of GABA agonist cocktail (Drug) or vehicle on post-test day. Data expressed
as mean ± SEM in difference score: the difference in time between post (post) and pre
(pre) test days of the CPP procedure; * denotes significant change in difference score
between post- and pre-test .
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4.4 DISCUSSION
The aim of this study was to determine the role of the mPFC in regulating diurnal
rhythms in reward. Our findings indicate that the mPFC is an important modulator of
rhythmic behavioural output from the reward system, as the diurnal rhythm in
amphetamine reward (Webb, et al., 2009) is lost with lesioning or pharmacological
inactivation of the mPFC. With either mPFC manipulation, the loss of rhythmicity
occurred via an increase in amphetamine reward at the nadir point, suggesting that
amphetamine becomes equally rewarding at all times of the day. Furthermore, the mPFC
appears to be exerting its rhythmic control over reward during both the acquisition and
expression of learned reward-place associations. mPFC infusion of GABA agonists
during either phase had an equal effect on the amphetamine CPP rhythm, a loss of timeof-day differences.

Several studies have investigated the role of the mPFC in CPP for drugs of abuse
(Tzschentke, 2007). Neurotoxic quinolinic acid lesions of the mPFC have little effect on
amphetamine CPP (Tzschentke, 1998b; Tzschentke & Smith, 1998) , while prelimbic (PL)
but not infralimbic (IL) lesions block cocaine-induced CPP during the light phase,
(Tzschentke & Smith, 1998b) but not during the dark phase (Zavala, Weber, Rice,
Alleweireldt, & Neisewander, 2003). Conversely, IL but not PL lesions block opiateinduced CPP during the light phase (Tzschentke & Smith, 1998). mPFC lesions have
similar effects on other drug-related behaviours. Neurotoxic lesions of the PL impair
cocaine-induced sensitization, lesions of the IL impair morphine sensitization, while
whole mPFC lesions did not affect amphetamine sensitization (Li & Wolf, 1997; Li,
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Wolf, & White, 1999; Tzschentke & Schmidt, 2008). Tzschentke & Schmidt (2008)
conclude that the mPFC does not mediate the rewarding effects of amphetamine, and
processing of morphine and cocaine reward is region specific. Here we report a
significant increase in amphetamine CPP with IL/PL lesions during the late dark phase
(ZT23), but not during the late-light phase (ZT11). The discrepancy between our
findings and previous reports with respect to the effects of mPFC lesions on drug CPP are
not immediately obvious but may reflect important procedural differences.

Firstly, previous CPP paradigms used at least three reward-paired trials during
conditioning. Under these conditions, significant psychostimulant-induced CPP was
observed in sham-operated animals irrespective of time-of-day (Tzschentke & Smith,
1998b; Zavala, et al., 2003). A single pairing with amphetamine was chosen to prevent
inducing circadian anticipatory behaviour and to minimize drug-induced changes to basal
mesolimbic activity. Roberts et al. (2002) previously reported that a daily rhythm in
cocaine self-administration disappears at high doses, suggesting a breakdown in circadian
regulation of the reward system and the development of an addictive phenotype.
Multiple pairings with the drug may have had the same effect as an increased dose,
disrupting baseline rhythms in reward and mPFC activity.

A second challenge in interpreting other studies investigating effects of mPFC
lesion or inactivation on reward (Franklin & Druhan, 2000; Ishikawa, Ambroggi, Nicola,
& Fields, 2008; Peters, LaLumiere, & Kalivas, 2008; Tzschentke & Smith, 1998a;
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Tzschentke & Smith, 1998b; Tzschentke, 1999), is that behavioural testing was
conducted over long periods of time. Rats were typically placed on a 12hr light/dark
cycle with lights on at 07:00 (ZT0), and experiments carried out during the light phase.
Presumably, behavioural testing coincides with the normal work period, or roughly ZT2
to ZT10. Significant time-of-day differences in amphetamine reward during this interval
with a peak (ZT5) and nadir (ZT11) have been reported (Webb, et al., 2009). mPFC
lesions caused a significant increase in amphetamine reward at nadir times, but not at
peak times. Thus, the lack of mPFC lesion effects on amphetamine CPP (T. M.
Tzschentke & W. J. Schmidt, 1998b) in other studies may reflect a testing interval that
included peaks and nadirs, causing time-dependent effects to be masked. Despite the
possible masking effects caused by long testing intervals, mPFC lesions still impair CPP
induced by another psychostimulant, cocaine (Tzschentke & Smith, 1998b; Tzschentke &
Schmidt, 1999). Tzschentke & Schmidt (1999) attributes the lack of mPFC lesion effects
on amphetamine CPP to evidence that amphetamine reward is predominantly mediated
by mesolimbic dopamine. Here we observe that the mPFC plays an important role in
regulating amphetamine CPP, while others have reported that mPFC inactivation by
GABA agonists increases methamphetamine self-administration and impairs
methamphetamine-seeking behaviour (Rocha & Kalivas, 2010). Thus, effects of mPFC
lesions on amphetamine CPP may be influenced by time-of-day and other procedural
parameters.

To our knowledge, this is the first study to have investigated the effects of acute
mPFC GABA agonist infusions on reward CPP. mPFC inactivation has been reported to
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impair several other reward-related behaviours. For instance, inactivation of the IL/PL
by GABA agonists induces cocaine-seeking behaviour in extinguished rats (Peters,
LaLumiere, et al., 2008). Alternatively, IL/PL inactivation does not impair the
suppression of cocaine-seeking behaviour during extinction training, nor reinstatement of
cocaine-seeking behaviour following abstinence (Peters, Vallone, Laurendi, & Kalivas,
2008). IL/PL inactivation also impairs learned goal-directed behaviours with decreased
cue-evoked operant bar-pressing for sucrose acquisition, and increased bar-pressing to
non-rewarded cues (Ishikawa, et al., 2008). It was shown that dorsal mPFC (ACA and
dorsal PL) inactivation is responsible for the former, while inactivation of ventral mPFC
(IL and ventral PL) the latter. Several researchers have suggested specialized roles of the
ventral and dorsal mPFC in goal-directed behaviours (Ghazizadeh, Ambroggi, Odean, &
Fields, 2012; Ishikawa, et al., 2008; LaLumiere, Smith, & Kalivas, 2012; Peters,
LaLumiere, et al., 2008; Peters, Vallone, et al., 2008). The ventral mPFC, specifically
the IL, is important for inhibiting inappropriate or non-rewarding responses, and similarly,
extinction of goal-directed behaviour. The dorsal mPFC, including the PL, is important
for the initiation of conditioned drug responses. It is possible that diurnal rhythms in
reward are controlled in a similar way, by daily oscillations in the underlying neural
mechanisms that mediate initiation and inhibition of reward behaviour. mPFC lesions or
inactivation disrupt these rhythms leading to constitutively elevated amphetamine reward.
However, the specific role of each subregion in mediating diurnal rhythms in reward has
yet to be determined. The influence of the IL and PL on goal-directed behaviour is
thought to be mediated by projections to the NAc shell and NAc core, respectively
(Berendse, Graaf, & Groenewegen, 2004; Sesack, Deutch, Roth, & Bunney, 1989). We
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previously observed a loss of the rhythm in neural activation in the NAc core and NAc
shell (chapter 3) with IL/PL lesions. However, the loss of rhythmicity in accumbal
activation occurred via a decrease in cFos-IR during the dark phase (ZT18), and thus
appears to be unrelated to the effects of mPFC lesions on amphetamine reward, which are
mediated by increased amphetamine CPP during the light phase (ZT11).

The loss of time-of-day differences in amphetamine CPP with mPFC lesions and
inactivation suggests that a rhythmic signal is emanating from the mPFC, which may be
driven by intrinsic clock gene oscillations (Angeles-Castellanos, et al., 2007; Li, et al.,
2009). Another possibility is that the mPFC is not intrinsically rhythmic but mediates a
rhythmic signal that originates elsewhere. This hypothesis is in line with the wellestablished role of the mPFC in integrating and modulating inputs from various reward
areas including the amygdala, hippocampus and VTA (Bechara, 2005), where a temporal
signal could be another kind of input. The VTA is a likely candidate for conveying a
timing signal to the mPFC as it is implicated in the regulation of reward (Kelley &
Berridge, 2002), and expresses diurnal rhythms in neural activation (see chapter 3).
Dopaminergic projections originating in the VTA innervate the mPFC (Thierry, Blanc,
Sobel, Stinus, & Golwinski, 1973), where diurnal differences in markers of dopamine
release have been reported (Sleipness, et al., 2008). Mesocortical dopamine is critical for
reward related learning (Wise, 2004), and exerts precise control over mPFC excitability
by regulating dopamine D1 and D2 receptor mediated feed forward inhibition (Tierney,
Thierry, Glowinski, Deniau, & Gioanni, 2008; Xu & Yao, 2010). Thus, an exogenous
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timing signal may be conveyed through diurnal variations in dopamine signalling and
D1/D2 dependent excitability.

The specific changes to reward behaviour following mPFC manipulation have led
many to suggest that the mPFC exerts top-down control over reward behaviour,
activating or inhibiting learned responses and shifting strategies in the face of changing
information (Bechara, 2005; Kroener & Lavin, 2010; Miller & Cohen, 2001; Peters,
LaLumiere, et al., 2008). This conception of the mPFC is consistent with the current
findings. We observed that amphetamine reward becomes persistently elevated
throughout the day with mPFC impairment, causing a loss of the daily reward rhythm.
These findings are consistent with the hypothesis that rhythms in reward are mediated by
a mechanism of negative regulatory control by the mPFC.
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CHAPTER 5:
Summary and Future Directions
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5.1 SUMMARY AND FUTURE DIRECTIONS
5.1.1 Diurnal rhythms in amphetamine and sex reward
A diurnal rhythm in reward, measured by conditioned place preference (CPP), for
sex (Fig. 2.1) and amphetamine (Fig. 2.2) was observed (Webb, Baltazar, Lehman, &
Coolen, 2009). The daily peak in amphetamine reward occurred during the early day
(ZT5), and was coincident with previously reported peaks for cocaine reward. The timeof-day difference between the peak and nadir in amphetamine reward persists in constant
darkness, suggesting that diurnal rhythms in reward are circadian in nature. In
comparison to amphetamine, the peak in sex reward was observed during the early night
(ZT17). The reasons for the phase disparity between drug and sex rhythms are not yet
known, but suggest multiple levels of regulation in the underlying reward circuits.

5.1.2 Diurnal rhythms in mesolimbic activity
Rhythms in reward were likely mediated by oscillations in the underlying neural
circuits. Thus, we characterized daily changes in mesolimbic dopamine activity, and
neural activation. Diurnal rhythms for the marker of dopamine synthesis, tyrosine
hydroxylase (TH), were observed in the VTA and the NAc (Fig. 2.4)(Webb et al., 2009),
but with different patterns of expression. The peak and nadir in TH protein in the NAc is
observed during the early night (ZT14) and during the mid day (ZT6), and coincides with
those of sex reward (Fig. 2.6). The rhythm in VTA TH expression was opposite that of
the NAc, with a peak in the mid day (ZT6) and a nadir just before the transition to dark
(ZT10), and overlaps with the daily rhythm in amphetamine reward (Fig. 2.6).
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Neural activation in the NAc (Fig.3.3), PFC (Fig. 3.4), and VTA (Fig. 3.5), was
also observed to vary with a diurnal rhythm, the phases of which were coincident. The
peaks in cFos immunoreactivity occurred during the mid night (ZT18), and the nadirs
near the light to dark transition (ZT10). Moreover, the number of activated dopamine
cells also varied by time-of-day in the VTA with a similar phase, and accounted for
approximately 20% of total activation. Overall, these findings demonstrate diurnal
regulation of the mesolimbic system, which is likely linked to the observed rhythms in
reward behaviour.

It is hypothesized that the peak in sex reward occurs when neural activation and
the potential for dopamine release in the NAc is highest (Fig. 2.6). For rats, this
coincides with the normal active period at night, when encounters with biologically
relevant stimuli are most likely. While correlations in TH and neural activation
potentially explain circadian regulation of natural rewards, the peak in amphetamine
reward coincides with a decreased likelihood for evoked NAc dopamine release (Fig. 2.6).
Amphetamine artificially increases extracellular dopamine in the NAc by blocking the
dopamine transporter (Seiden, Sabol, & Ricaurte, 1993; Wise & Bozarth, 1987). Thus,
the peak in amphetamine reward may be linked to increased dopamine receptor
sensitization at a time when extracellular dopamine is normally low. However, these
hypotheses derive from the activity of mesolimbic dopamine projections alone. Given
the anatomical and neurochemical complexity of the reward system (Kelley & Berridge,
2002; Koob, 2006; Sesack, Carr, Omelchenko, & Pinto, 2003), circadian regulation of
reward likely occurs at multiple sites of action. Research on the circadian regulation of
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the mesolimbic system has mainly focused on markers of dopamine signalling (McClung
et al., 2005; Sleipness, Jansen, Schenk, & Sorg, 2008; Sleipness, Sorg, & Jansen, 2007;
Webb, Baltazar, Wang, et al., 2009), while the role of the non-dopaminergic elements has
largely been unexplored. Future experiments will focus on characterizing diurnal
rhythms in activity of other major neurotransmitters in the mesolimbic system, with a
particular focus on glutamate signalling.

5.1.3 The medial prefrontal cortex modulates rhythms in reward and mesolimbic activity
Diurnal rhythms in reward led us to investigate the nature of the timing
mechanism that drives them. Clock genes drive molecular oscillations in the master
circadian clock, the SCN (Ko & Takahashi, 2006), and have been localized to some
reward-related brain regions (Angeles-Castellanos, Mendoza, & Escobar, 2007; Iijima,
Nikaido, Akiyama, Moriya, & Shibata, 2002; Li, Liu, Jiang, & Lu, 2009; Uz,
Akhisaroglu, Ahmed, & Manev, 2003). Here, we report diurnal fluctuations in the
concentration of clock proteins (Per1 and BMAL1) in the NAc with differential temporal
expression (Fig.2.5), but not in the VTA, suggesting that observed rhythms mesolimbic
and neural activity in this region is mediated by a timing signal originating elsewhere.

The role of the mPFC in regulating observed rhythms in amphetamine-induced
CPP, and in neural activation in the NAc and VTA was investigated. The mPFC is a
good candidate for conferring rhythmicity upon the reward system as it is important for
the regulation of reward (Hyman, Malenka, & Nestler, 2006; Miller & Cohen, 2001;
Ridderinkhof, van den Wildenberg, Segalowitz, & Carter, 2004) and expresses rhythms
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in neurotransmitter activity (Castaneda, de Prado, Prieto, & Mora, 2004) and clock gene
expression (Angeles-Castellanos, et al., 2007; Li, et al., 2009). Lesions of the mPFC
caused an attenuation of neural activation at peak time (ZT18) in the NAc core and shell
(Fig.3.7), such that the diurnal rhythm was altogether lost, with no effect on the rhythms
in the VTA. These observations suggest that the NAc may be an important convergence
point for timing signals conveyed by corticoaccumbal glutamatergic and mesolimbic
dopaminergic projections.

As rhythms in VTA activity do not appear to be driven by local clock gene
activity or by the PFC, the timing signal responsible for VTA rhythmicity must originate
elsewhere. As previously mentioned, a potential signalling pathway between the SCN
and the VTA has been identified via hypothalamic orexin neurons (Deurveilher & Semba,
2005; Korotkova, Sergeeva, Eriksson, Haas, & Brown, 2003), which are ideally
positioned to transmit an entrainment signal to the mesolimbic system. Again, the orexin
system has been implicated in reward (Aston-Jones, Smith, Moorman, & Richardson,
2009; Harris, Wimmer, & Aston-Jones, 2005) via its regulation of VTA dopamine
neurons, which been shown to vary by time-of-day (Moorman & Aston-Jones, 2010).
Moreover, phase shifting or eliminating SCN output alters diurnal rhythms of orexin
signalling (Marston et al., 2008; Zhang et al., 2004). This initial evidence suggests that
hypothalamic orexin neurons are important for modulating rhythms in mesolimbic
activity, however additional experiments will be necessary to elucidate the underlying
mechanism and behavioural consequences.
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As the PFC was important for modulating rhythms in mesolimbic activity, we
investigated its capacity for effecting rhythms in reward behaviour. Similarly, PFC
lesions affected a significant increase in amphetamine reward at the nadir point (ZT11),
resulting in a loss of time-of-day differences (Fig. 4.2). Next, we determined if the role of
the PFC in modulating reward rhythmicity was differentially exerted during the
acquisition of conditioned reward-place association or upon its recall (Fig. 4.3-4)
Pharmacological inactivation of the mPFC has the same effect as lesions irrespective of
the phase of conditioning. The mPFC is important for the precise top-down control of
goal-directed behaviours (Miller & Cohen, 2001) and thus, may relegate reward to times
when encountering a rewarding stimulus is increased. Based on these findings, it is
hypothesized that mPFC is exerting its influence over the reward system via a mechanism
of negative regulatory control, which is consistent with the overall role of the mPFC of
inhibitory control (Peters, Kalivas, & Quirk, 2009; Peters, LaLumiere, & Kalivas, 2008;
Peters, Vallone, Laurendi, & Kalivas, 2008; Van den Oever, Spijker, Smit, & De Vries,
2010). Consistent with this hypothesis, the in peak amphetamine reward may coincide
with the nadir in mPFC inhibition. Thus, lesioning or inactivating the mPFC results in
amphetamine being rewarding at all times of day.

This body of work has provided an extensive characterization of diurnal rhythms
in reward and mesolimbic activity. It provides the first example of such rhythms for
natural reinforcers, and extends those of psychostimulants to include multiple time-points
across the day. Furthermore, it has provided some potentially meaningful correlations
between reward behaviours and rhythms in mesolimbic activity, and established the PFC
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as an important locus for regulating the timing of reward. This work has investigated the
relationship between rhythms in mesolimbic activity and reward under baseline
conditions. Additional experiments will be necessary to determine if rewarding stimuli
have a differential effect on inducing neuroplastic changes to the structure and function
of mesolimbic circuits across the day. Furthermore, there are other questions that need to
be answered. For instance, what is the role of the SCN in regulating or entraining
rhythms in reward?; how do rhythmic glutamate and dopamine signals converging on the
nucleus accumbens interact to generate rhythms in reward?; what is the nature of the
timing mechanism driving mPFC rhythms?
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